<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//www.pharmaceutical-business-review.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6849aaruna_and_open_biosystems_codevelop_pluripotent_stem_cel-2/</loc>
		<lastmod>2009-04-02T02:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c549fintrinsic_bioprobes_signs_127_million_contract_wit-2/</loc>
		<lastmod>2009-04-02T02:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/544a0orexigen_names_new_president_an-2/</loc>
		<lastmod>2009-04-02T02:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/30482osteologixs_osteoporosis_drug_patent_upheld_by_european_patent_o-2/</loc>
		<lastmod>2009-04-02T02:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec49dgenentechs_brain_cancer_drug_wins_positive_review_from_fda_-2/</loc>
		<lastmod>2009-04-02T02:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c4480cepheid_launches_new_bacterial_detection-2/</loc>
		<lastmod>2009-04-02T02:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytokinetics_reports_positive_results_from_phase_iia_heart_failure_trial_020409-2/</loc>
		<lastmod>2009-04-02T05:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/osiris_therapeutics_to_accelerate_transfer_of_osteocel_business_020409-2/</loc>
		<lastmod>2009-04-02T05:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0548bsanofiaventis_acquires_laboratorios_ken-2/</loc>
		<lastmod>2009-04-02T06:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0149dschiff_nutrition_names_two_new_board_me-2/</loc>
		<lastmod>2009-04-02T06:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5d4b5cyprotex_names_new_chief_commercial_of-2/</loc>
		<lastmod>2009-04-02T06:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbotts_dyslipidemia_trial_meets_primary_endpoints_020409-2/</loc>
		<lastmod>2009-04-02T06:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3c4b3gw_to_obtain_gbp8_million_milestone_payment_from_alm-2/</loc>
		<lastmod>2009-04-02T06:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f94bcroche_introduces_new_bacterial_detection_test_-2/</loc>
		<lastmod>2009-04-02T06:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cc4b5tenet_completes_sale_of_usc_university_hospital_and_kenneth_norris_hos-2/</loc>
		<lastmod>2009-04-02T06:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9b491suntech_launches_new_ambulatory_blood_pressure_monitoring_sof-2/</loc>
		<lastmod>2009-04-02T06:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2948cnovavax_closes_11_million_common_stock_sale_to_cadilas_subsi-2/</loc>
		<lastmod>2009-04-02T06:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/avexa_reaches_first_critical_evaluation_point_in_phase_iii_anti_hiv_drug_study_020409-2/</loc>
		<lastmod>2009-04-02T07:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dor_biopharma_signs_equity_investment_agreement_with_numoda_020409-2/</loc>
		<lastmod>2009-04-02T08:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/avidas_introduces_new_scalacort_defence_kit_020409-2/</loc>
		<lastmod>2009-04-02T08:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arena_reports_positive_results_from_phase_iii_obesity_trial_020409-2/</loc>
		<lastmod>2009-04-02T08:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/43495patheon_forms_alliance_with_ke-2/</loc>
		<lastmod>2009-04-02T09:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5d4a0altea_signs_development_and_commercialization_agreement_with_amylin_and_-2/</loc>
		<lastmod>2009-04-02T09:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regeneron_initiates_enrollment_in_phase_iii_gout_program_020409-2/</loc>
		<lastmod>2009-04-02T09:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e04bdinverness_medical_innovations_names_new_board_m-2/</loc>
		<lastmod>2009-04-02T09:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e548anebraska_orthopaedic_hospital_selects_anesthesia_information_system_fro-2/</loc>
		<lastmod>2009-04-02T09:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5849cmisonix_signs_new_distribution_agreement_with_sophysa_be-2/</loc>
		<lastmod>2009-04-02T09:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1448akissei_and_eisai_sign_licensing_agre-2/</loc>
		<lastmod>2009-04-02T09:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/archemix_initiates_phase_iia_carotid_endarterectomy_trial_020409-2/</loc>
		<lastmod>2009-04-02T09:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2d499envivo_and_mitsubishi_tanabe_pharma_sign_licensing_agre-2/</loc>
		<lastmod>2009-04-02T09:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ligand_and_gsk_collaboration_identifies_new_lead_compound_020409-2/</loc>
		<lastmod>2009-04-02T10:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/46490genomma_lab_acquires_medicinas_y_medicamentos_nacio-2/</loc>
		<lastmod>2009-04-02T10:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2b499xcellerex_names_new_board_m-2/</loc>
		<lastmod>2009-04-02T10:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hyperion_reports_positive_results_from_phase_ii_urea_cycle_disorders_trial_020409-2/</loc>
		<lastmod>2009-04-02T10:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/734b6mdrna_signs_asset_purchase_agreement_with_par_pharmaceu-2/</loc>
		<lastmod>2009-04-02T10:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/674a2valeant_pharmaceuticals_names_new_board_m-2/</loc>
		<lastmod>2009-04-02T10:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arca_biopharma_reports_overall_survival_benefit_from_heart_failure_trial_020409-2/</loc>
		<lastmod>2009-04-02T10:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bc482abbott_initiates_study_of_absolute_pro_peripheral_stent_s-2/</loc>
		<lastmod>2009-04-02T10:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8d485chemimage_and_next_breath_form_research_partne-2/</loc>
		<lastmod>2009-04-02T10:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8748fondine_wins_additional_health_canadian_licenses_for_photodisinfection_s-2/</loc>
		<lastmod>2009-04-02T10:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/164bdarthrocare_names_new_senior_vice_president_an-2/</loc>
		<lastmod>2009-04-02T10:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/724aenuevolutions_partner_merck_enters_second_phase_of_research_collabor-2/</loc>
		<lastmod>2009-04-02T11:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dyax_cuts_60_jobs_020409-2/</loc>
		<lastmod>2009-04-02T11:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi_aventis_wins_australian_approval_for_influenza_vaccine_020409-2/</loc>
		<lastmod>2009-04-02T12:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmaceutical_executives_reach_out_to_each_other_to_combat_the_current_industry_crisis_030409-2/</loc>
		<lastmod>2009-04-03T05:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f4486sanofi_seeks_to_acquire_solvays_pharma_div-2/</loc>
		<lastmod>2009-04-03T06:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4c4afshire_doubles_us_sales_-2/</loc>
		<lastmod>2009-04-03T06:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biolase_and_nlt_sign_settlement_agreement_030409-2/</loc>
		<lastmod>2009-04-03T06:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genzyme_acquires_rights_to_multiple_sclerosis_drug_from_bayer_030409-2/</loc>
		<lastmod>2009-04-03T06:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alliance_healthcard_acquires_access_plans_usa_030409-2/</loc>
		<lastmod>2009-04-03T06:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/acacia_pharma_initiates_phase_iia_cachexia_trial_030409-2/</loc>
		<lastmod>2009-04-03T07:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hemaquest_wins_two_european_orphan_drug_designations_for_blood_drug_030409-2/</loc>
		<lastmod>2009-04-03T07:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/diamedica_reports_top_line_results_from_phase_iia_diabetes_trial_030409-2/</loc>
		<lastmod>2009-04-03T07:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/834b1insite_vision_signs_licensing_and_distribution_agreement_with_n-2/</loc>
		<lastmod>2009-04-03T08:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b14a7depomed_completes_enrollment_in_phase_iii_hot_flashes_-2/</loc>
		<lastmod>2009-04-03T08:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fa4a4covaris_launches_dna_shearing_se-2/</loc>
		<lastmod>2009-04-03T08:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/664bashire_files_patent_infringement_lawsuit_against_natco_p-2/</loc>
		<lastmod>2009-04-03T08:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a348ccanon_acquires_virtual_im-2/</loc>
		<lastmod>2009-04-03T08:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f24b6xanodynes_menorrhagia_drug_granted_priority_review_b-2/</loc>
		<lastmod>2009-04-03T08:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bd49flannett_to_supply_digoxin_tablets_-2/</loc>
		<lastmod>2009-04-03T08:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e548btraversa_therapeutics_raises_5_million_in_series_b_financ-2/</loc>
		<lastmod>2009-04-03T08:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a14a1jazz_pharmaceuticalss_ceo_re-2/</loc>
		<lastmod>2009-04-03T08:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boston_scientific_announces_key_rulings_in_stent_litigation_with_jj_030409-2/</loc>
		<lastmod>2009-04-03T08:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e648anovartis_wins_eu_approval_for_japanese_encephalitis_va-2/</loc>
		<lastmod>2009-04-03T08:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9a4a8osmetech_signs_distribution_agreement_with_fisher_healt-2/</loc>
		<lastmod>2009-04-03T08:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0a486tongjitang_chinese_medicines_acquires_jingfang_for_rmb60_mi-2/</loc>
		<lastmod>2009-04-03T08:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0448bdelsite_files_chapter_7_bankruptcy_prote-2/</loc>
		<lastmod>2009-04-03T09:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/544a5recordati_signs_licensing_agreement_with_alm-2/</loc>
		<lastmod>2009-04-03T09:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/23498cardionet_to_acquire_biotel_for_14_mi-2/</loc>
		<lastmod>2009-04-03T09:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/314aecaraco_pharmaceutical_launches_generic_seizure-2/</loc>
		<lastmod>2009-04-03T09:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d84a8monosol_rx_wins_new_us_p-2/</loc>
		<lastmod>2009-04-03T09:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/784a6amicas_completes_acquisition_of_em-2/</loc>
		<lastmod>2009-04-03T09:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/114a0micromet_wins_2_million_milestone_payment_from_ny-2/</loc>
		<lastmod>2009-04-03T09:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ce483quantum_genomics_wins_1_million_research_funding_from-2/</loc>
		<lastmod>2009-04-03T09:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/004aeredpoint_bio_terminates_collaboration_and_licensing_agreement_with_giv-2/</loc>
		<lastmod>2009-04-03T09:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7a49fintranexus_signs_distribution_agreement_with_med-2/</loc>
		<lastmod>2009-04-03T09:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fd495synergetics_signs_new_agreement_with_codman__shur-2/</loc>
		<lastmod>2009-04-03T10:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec49bldr_wins_fda_clearance_for_roia_alif_d-2/</loc>
		<lastmod>2009-04-03T10:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cb485teva_launches_generic_adhd_drug_-2/</loc>
		<lastmod>2009-04-03T10:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2649asorin_wins_ce_mark_for_esprit_pace-2/</loc>
		<lastmod>2009-04-03T10:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/plethora_solutions_amends_licensing_agreement_with_sciele_pharma-2/</loc>
		<lastmod>2009-04-03T10:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c04b0cellumen_launches_new_alzheimers_screening-2/</loc>
		<lastmod>2009-04-03T10:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b6490stem_cell_therapy_launches_new_cosmetic_face_-2/</loc>
		<lastmod>2009-04-03T10:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/304b8imedica_launches_new_electronic_health_record_and_practice_management_-2/</loc>
		<lastmod>2009-04-03T10:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/stemcells_completes_acquisition_of_operating_assets_and_businesses_of_scs-2/</loc>
		<lastmod>2009-04-03T10:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quatrx_completes_enrollment_in_phase_iii_vaginal_atrophy_trial_030409-2/</loc>
		<lastmod>2009-04-03T10:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/344b2wyeth_adopts_dyadem_phapro_software_to_enhance_risk_assess-2/</loc>
		<lastmod>2009-04-03T11:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/karo_bio_reports_positive_results_from_diabetes_study_030409-2/</loc>
		<lastmod>2009-04-03T11:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/harvest_technologies_reports_encouraging_interim_results_from_ischemia_trial_030409-2/</loc>
		<lastmod>2009-04-03T11:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celera_announces_resignation_of_joel_jung_as_cfo_appoints_ugo_deblasi_as_its_new_cfo_090406-2/</loc>
		<lastmod>2009-04-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arkansas_childrens_hospital_installs_toshibas_aquilion_one_060409-2/</loc>
		<lastmod>2009-04-06T02:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f64a3angiodynamics_q3_net_income_dec-2/</loc>
		<lastmod>2009-04-06T02:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c6482novabay_q4_net_loss_w-2/</loc>
		<lastmod>2009-04-06T02:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/664b3bruker_completes_acquisition_of_varians_accel_instruments_subsi-2/</loc>
		<lastmod>2009-04-06T02:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9e4abshire_to_close_owings_mills_drug_manufacturing_-2/</loc>
		<lastmod>2009-04-06T02:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/haemonetics_announces_change_to_board_of_directors_090406-2/</loc>
		<lastmod>2009-04-06T06:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immucor_posts_net_income_of_195_million_for_q3_fiscal_2009_090406-2/</loc>
		<lastmod>2009-04-06T07:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nitec_pharma_grants_arthritis_drug_distribution_rights_to_mundipharma_060409-2/</loc>
		<lastmod>2009-04-06T07:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alexion_files_nda_for_blood_disorder_drug_in_japan_060409-2/</loc>
		<lastmod>2009-04-06T08:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6f4adtaro_wins_fda_approval_for_generic_seizure-2/</loc>
		<lastmod>2009-04-06T09:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e0484savient_to_sell_593_million_shares_in_registered_direct_off-2/</loc>
		<lastmod>2009-04-06T09:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2849cppd_acquires_magen_biosciences_for_145_mi-2/</loc>
		<lastmod>2009-04-06T09:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5049fsinobiopharma_signs_export_agreement_with_kin-2/</loc>
		<lastmod>2009-04-06T09:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sepracor_files_nda_for_seizure_drug_060409-2/</loc>
		<lastmod>2009-04-06T09:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6749akinetic_concepts_and_carroll_hospital_group_form_partne-2/</loc>
		<lastmod>2009-04-06T09:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5a482charles_river_to_acquire_piedmont_research_center_for_46_mi-2/</loc>
		<lastmod>2009-04-06T09:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/insmed_completes_sale_of_follow_on_biologics_business_to_merck_060409-2/</loc>
		<lastmod>2009-04-06T10:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/094baeisai_signs_licensing_agreement_with_nobelp-2/</loc>
		<lastmod>2009-04-06T10:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/044bbmedquist_names_new_senior_vice_president_of_sales_and_mark-2/</loc>
		<lastmod>2009-04-06T10:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kai_pharmaceuticals_initiates_phase_iia_pain_trial_060409-2/</loc>
		<lastmod>2009-04-06T10:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9a4a3torax_medical_initiates_gastroesophageal_reflux_disease_-2/</loc>
		<lastmod>2009-04-06T10:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f9496arthrovisions_patent_not_infringed_by_chondrometrics_says_german_-2/</loc>
		<lastmod>2009-04-06T10:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/154acdbmotion_and_allscripts_form_partne-2/</loc>
		<lastmod>2009-04-06T10:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/704abeclinicalworks_and_endocrine_society_form_partne-2/</loc>
		<lastmod>2009-04-06T10:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9349boctoplus_obtains_new_drug_delivery_technology_evaluation_con-2/</loc>
		<lastmod>2009-04-06T10:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/46483cti_wins_second_payment_of_65_million_from_spectrum_pharmaceut-2/</loc>
		<lastmod>2009-04-06T10:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/684b7medicis_obtains_notice_of_allowance_for_acne-2/</loc>
		<lastmod>2009-04-06T10:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ae4b5ipauctions_to_sell_medical_patent_and_patent_application_of_-2/</loc>
		<lastmod>2009-04-06T10:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cardima_wins_ce_mark_for_new_surgical_ablation_system_060409-2/</loc>
		<lastmod>2009-04-06T11:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/de4bbedwards_lifesciences_introduces_new_software_for_flotrac_s-2/</loc>
		<lastmod>2009-04-06T11:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_wins_fda_approval_for_kidney_cancer_drug_060409-2/</loc>
		<lastmod>2009-04-06T11:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/repligen_licenses_patent_rights_for_bipolar_disorder_drug_from_mclean_hospital_060409-2/</loc>
		<lastmod>2009-04-06T11:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emd_serono_to_open_research_site_in_massachusetts_060409-2/</loc>
		<lastmod>2009-04-06T12:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seattle_genetics_names_vaughn_himes_as_evp_technical_operations_090407-2/</loc>
		<lastmod>2009-04-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/solvay_names_barry_hayter_as_general_manager_canada_090407-2/</loc>
		<lastmod>2009-04-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mindray_to_showcase_new_products_at_cmef_090407-2/</loc>
		<lastmod>2009-04-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ed4afallos_therapeutics_raises_468_million_in_common_stock_off-2/</loc>
		<lastmod>2009-04-07T00:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b449bhorizon_blue_cross_signs_regional_services_contract_with_enzo_clinical-2/</loc>
		<lastmod>2009-04-07T00:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bc484akela_pharma_q4_net_loss_w-2/</loc>
		<lastmod>2009-04-07T00:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5c4a4santaruss_nda_for_zegerid_tablet_product_accepted_for_review_b-2/</loc>
		<lastmod>2009-04-07T00:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cb4a4bristolmyers_squibb_extends_us_agreement_with_o-2/</loc>
		<lastmod>2009-04-07T00:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/china_biologic_products_2008_net_income_up_46_070409-2/</loc>
		<lastmod>2009-04-07T05:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a14beastrazeneca_wins_swedish_clearance_for_divestment_of_otc_product_port-2/</loc>
		<lastmod>2009-04-07T06:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7849ecerapedics_secures_15_million_in_series_b_fina-2/</loc>
		<lastmod>2009-04-07T06:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/234b3nuvera_signs_licensing_agreement_with_ve-2/</loc>
		<lastmod>2009-04-07T06:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5f4aaariad_pharmaceuticals_names_new_board_m-2/</loc>
		<lastmod>2009-04-07T06:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c049aavineuro_initiates_phase_i_clinical_studies_of_alzheimers-2/</loc>
		<lastmod>2009-04-07T06:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d34acintellidot_names_new_chairman_an-2/</loc>
		<lastmod>2009-04-07T06:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/584beastrazeneca_files_patent_infringement_lawsuit_against_a-2/</loc>
		<lastmod>2009-04-07T06:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/374beceleras_cfo_re-2/</loc>
		<lastmod>2009-04-07T06:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/614aamayer_gains_distribution_rights_for_today_s-2/</loc>
		<lastmod>2009-04-07T06:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ed48eimmucor_q3_net_income_increases_sli-2/</loc>
		<lastmod>2009-04-07T07:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4e4adxtl_biopharmaceuticals_2008_net_loss_na-2/</loc>
		<lastmod>2009-04-07T07:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/734b6capsule_launches_new_pointofcare_connectivity_d-2/</loc>
		<lastmod>2009-04-07T07:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2c497serentis_initiates_recruitment_in_phase_ii_dermatitis_-2/</loc>
		<lastmod>2009-04-07T07:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/57494hospira_introduces_generic_tazocin_-2/</loc>
		<lastmod>2009-04-07T07:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e0495biovail_appoints_new_vp_of_intellectual_property_for_biovail_laborat-2/</loc>
		<lastmod>2009-04-07T07:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/halozyme_initiates_dosing_in_phase_i_cancer_trial_070409-2/</loc>
		<lastmod>2009-04-07T08:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sarcode_reports_positive_results_from_phase_i_ocular_inflammatory_trial_070409-2/</loc>
		<lastmod>2009-04-07T08:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/navigenics_names_jonathan_lord_as_president_and_ceo_090407-2/</loc>
		<lastmod>2009-04-07T08:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/61492pharmaxis_names_new_board_m-2/</loc>
		<lastmod>2009-04-07T08:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9a489noteworthy_medical_systems_names_new_chairman_and_-2/</loc>
		<lastmod>2009-04-07T09:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/covance_announces_new_clinical_development_offices_in_chile_peru_and_expands_argentina_office_090407-2/</loc>
		<lastmod>2009-04-07T09:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/324b5impax_confirms_patent_challenge_relating_to_dialysis-2/</loc>
		<lastmod>2009-04-07T09:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f3490alseres_obtains_spa_agreement_for_phase_iii_trial_of_altr-2/</loc>
		<lastmod>2009-04-07T09:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f44b3omegagenesis_and_ua_college_of_medicine_sign_collaboration_agre-2/</loc>
		<lastmod>2009-04-07T09:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4f486bioduro_and_roche_partner_to_provide_drug_discovery_ser-2/</loc>
		<lastmod>2009-04-07T09:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1349fastrazeneca_obtains_fda_complete_response_letter_for_asthma-2/</loc>
		<lastmod>2009-04-07T09:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/insite_vision_wins_canadian_approval_for_conjunctivitis_drug_070409-2/</loc>
		<lastmod>2009-04-07T09:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1e4a1interleukin_genetics_and_labec_sign_licensing_agre-2/</loc>
		<lastmod>2009-04-07T09:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8848fuluru_to_acquire_york_pha-2/</loc>
		<lastmod>2009-04-07T09:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/db4bbsunquest_and_upmc_expand_partne-2/</loc>
		<lastmod>2009-04-07T09:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/844b5evalve_initiates_postmarket_study_of_mitraclip_th-2/</loc>
		<lastmod>2009-04-07T09:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/454aeaerovance_raises_38_million_in_equity_fina-2/</loc>
		<lastmod>2009-04-07T10:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e1497cohera_medical_names_new_vice_president_of_manufact-2/</loc>
		<lastmod>2009-04-07T10:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda_expands_sales_and_marketing_operations_in_europe-2/</loc>
		<lastmod>2009-04-07T10:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/894b4intelgenx_and_cary_file_nda_for_depression-2/</loc>
		<lastmod>2009-04-07T10:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b04a1nugen_names_new_managing_director_of_european_field_opera-2/</loc>
		<lastmod>2009-04-07T10:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2a4adcryolife_wins_17_million_funding_from_us_department_of_de-2/</loc>
		<lastmod>2009-04-07T10:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristol_myers_and_astrazenecas_onglyza_wins_positive_review_from_fda_panel_070409-2/</loc>
		<lastmod>2009-04-07T10:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/084b7seattle_genetics_signs_collaboration_agreement_with_mille-2/</loc>
		<lastmod>2009-04-07T10:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/42499sinobiopharma_seeks_chinese_patent_to_develop_antihypertension_-2/</loc>
		<lastmod>2009-04-07T10:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/01495inovio_biomedical_names_new_board_m-2/</loc>
		<lastmod>2009-04-07T10:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6a4bbbioject_wins_fda_clearance_for_zetajet_injection_therapy_s-2/</loc>
		<lastmod>2009-04-07T10:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/56496emisphere_techonologies_and_aaipharma_form_all-2/</loc>
		<lastmod>2009-04-07T10:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_wins_european_authorization_for_pneumococcal_vaccine_070409-2/</loc>
		<lastmod>2009-04-07T12:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amylin_lilly_and_alkermes_report_positive_results_from_diabetes_trial_070409-2/</loc>
		<lastmod>2009-04-07T12:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tongjitang_chinese_medicines_acquires_jingfang_for_rmb60m_080409-2/</loc>
		<lastmod>2009-04-08T05:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/osiris_initiates_treatment_in_phase_ii_myocardial_infarction_trial_080409-2/</loc>
		<lastmod>2009-04-08T06:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biovista_reports_positive_efficacy_results_from_multiple_sclerosis_trial_080409-2/</loc>
		<lastmod>2009-04-08T06:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cardionet_to_acquire_biotel_for_14m_080409-2/</loc>
		<lastmod>2009-04-08T06:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tekmiras_partner_alnylam_initiates_phase_i_liver_cancer_trial_080409-2/</loc>
		<lastmod>2009-04-08T07:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/714b1sidmap_signs_new_contracts_with_two_japanese_pharmaceutical_comp-2/</loc>
		<lastmod>2009-04-08T08:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4849ccentice_raises_4_million_in_fina-2/</loc>
		<lastmod>2009-04-08T08:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gileads_phase_iii_hypertension_trial_meets_primary_endpoints_080409-2/</loc>
		<lastmod>2009-04-08T08:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/064b1wellgen_names_new_president_an-2/</loc>
		<lastmod>2009-04-08T09:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9a482arrayit_and_parkinsons_institute_of_california_form_new_collabor-2/</loc>
		<lastmod>2009-04-08T09:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/014bbcore_essence_orthopaedics_names_new_cha-2/</loc>
		<lastmod>2009-04-08T09:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8f498covance_opens_new_offices_in_chile_and-2/</loc>
		<lastmod>2009-04-08T09:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_terminates_one_of_its_phase_iii_breast_cancer_trials_080409-2/</loc>
		<lastmod>2009-04-08T09:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e1498cianna_medical_raises_additional_10_million_in_fina-2/</loc>
		<lastmod>2009-04-08T09:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/664bflantheus_acquires_us_canadian_and_australian_rights_to_epixs_mra_-2/</loc>
		<lastmod>2009-04-08T09:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/df4a9paradigm_medical_names_new_pres-2/</loc>
		<lastmod>2009-04-08T09:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0049cbiowa_signs_licensing_agreement_with_sanofiav-2/</loc>
		<lastmod>2009-04-08T10:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/da4abbsd_medical_names_new_president_and_board_m-2/</loc>
		<lastmod>2009-04-08T10:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6d49bgenenews_names_new_board_m-2/</loc>
		<lastmod>2009-04-08T10:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ef485navigenics_names_new_president_an-2/</loc>
		<lastmod>2009-04-08T10:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/464b8transmolecular_names_new_president_an-2/</loc>
		<lastmod>2009-04-08T10:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/994aamisonix_sells_ultrasonic_laboratory_business_to_isonix_for_35_mi-2/</loc>
		<lastmod>2009-04-08T10:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b2498daiichi_sankyo_and_lilly_launch_heart_drug_-2/</loc>
		<lastmod>2009-04-08T10:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/affitech_wins_new_european_patent_for_antibody_screening_technology_080409-2/</loc>
		<lastmod>2009-04-08T10:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/744b9insightec_wins_fda_approval_for_label_change_of_noninvasive_fibroid_trea-2/</loc>
		<lastmod>2009-04-08T10:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ea495watson_launches_benign_prostatic_hyperplasia_drug_-2/</loc>
		<lastmod>2009-04-08T10:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6648fsanofiaventis_launches_aplenzin_extendedrelease_tablets_in-2/</loc>
		<lastmod>2009-04-08T10:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clinical_data_to_divest_cogenics_division_to_beckman_coulter_080409-2/</loc>
		<lastmod>2009-04-08T10:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cardiodynamics_posts_net_sales_of_51_million_for_q1_2009_down_12_090409-2/</loc>
		<lastmod>2009-04-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medmira_appoints_andre_archimbaud_to_board_of_directors_090409-2/</loc>
		<lastmod>2009-04-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ge_healthcare_it_and_microsoft_business_solutions_partner_to_deliver_healthcare_it_administration_solutions_090409-2/</loc>
		<lastmod>2009-04-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1849ecornerstones_chief_accounting_officer_re-2/</loc>
		<lastmod>2009-04-08T23:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b64bbapplied_biosystems_and_mds_analytical_introduce_new_mass_spectro-2/</loc>
		<lastmod>2009-04-09T00:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/93496global_med_licenses_healthcare_information_solutions_to_homburg_c-2/</loc>
		<lastmod>2009-04-09T00:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sra_wins_us_department_of_health_and_human_services_deal_090409-2/</loc>
		<lastmod>2009-04-09T00:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e7497transgenomic_completes_licensing_option_with_danafarber_cancer_inst-2/</loc>
		<lastmod>2009-04-09T00:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c349fseattle_genetics_makes_senior_management_ch-2/</loc>
		<lastmod>2009-04-09T00:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ca4a5aphios_obtains_new_japanese_p-2/</loc>
		<lastmod>2009-04-09T00:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0448aallergy_therapeutics_signs_distribution_agreement_with_nycomed_c-2/</loc>
		<lastmod>2009-04-09T01:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bb482genprobe_completes_acquisition_of_tepnel_life_sci-3/</loc>
		<lastmod>2009-04-09T01:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cb4a9pfizer_reorganizes_operating_structure_makes_key_management_ch-3/</loc>
		<lastmod>2009-04-09T01:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/37486encision_signs_supply_and_licensing_agreement_with_intuitive_sur-3/</loc>
		<lastmod>2009-04-09T01:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/97484humanaone_launches_new_health_insurance_pr-2/</loc>
		<lastmod>2009-04-09T04:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/elan_and_wyeth_to_discontinue_highest_dosing_regimen_in_alzheimers_study_090409-2/</loc>
		<lastmod>2009-04-09T04:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mithridion_reports_encouraging_results_from_phase_i_alzheimers_trial_090409-2/</loc>
		<lastmod>2009-04-09T05:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/intercell_initiates_phase_i_pneumonia_vaccine_trial_090409-3/</loc>
		<lastmod>2009-04-09T05:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dc4a7integrated_biopharmas_ceo_and_president_re-3/</loc>
		<lastmod>2009-04-09T06:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/10486thallion_pharmaceuticals_q1_net_loss_decr-2/</loc>
		<lastmod>2009-04-09T06:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tibotec_wins_canadian_approval_for_new_indication_of_hiv_drug_090409-2/</loc>
		<lastmod>2009-04-09T06:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/74498wright_medical_introduces_prophecy_preoperative_navig-2/</loc>
		<lastmod>2009-04-09T06:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/444bamedtronic_begins_abdominal_aortic_aneurysms_-2/</loc>
		<lastmod>2009-04-09T06:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/champions_biotechnology_sets_up_uk_subsidiary_090409-2/</loc>
		<lastmod>2009-04-09T06:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/984a5adcock_ingram_to_acquire_cmsa_for_227_mi-2/</loc>
		<lastmod>2009-04-09T06:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/asterands_partner_btg_to_initiate_phase_iia_migraine_studies_090409-2/</loc>
		<lastmod>2009-04-09T06:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cephalon_reports_positive_results_from_phase_iii_jet_lag_sleepiness_study_090409-2/</loc>
		<lastmod>2009-04-09T06:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6d4a1tobira_initiates_phase_iia_proofofconcept_study_for_hiv-2/</loc>
		<lastmod>2009-04-09T07:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1e4a3chemgenex_secures_a10_million_in_fina-2/</loc>
		<lastmod>2009-04-09T07:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/694a2nmt_medical_wins_fda_premarket_approval_for_cardiac_septal_repair_im-2/</loc>
		<lastmod>2009-04-09T07:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/63498sinobiopharma_names_new_director_of_mark-2/</loc>
		<lastmod>2009-04-09T08:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ad48daetna_and_mississippi_health_partners_sign_new_con-2/</loc>
		<lastmod>2009-04-09T08:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6c4bfcerulean_pharma_names_new_president_an-2/</loc>
		<lastmod>2009-04-09T08:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zosano_pharma_reports_positive_phase_ii_results_from_osteoporosis_trial_090409-2/</loc>
		<lastmod>2009-04-09T08:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/db4acsanofiaventis_to_acquire_medley_for_e500_mill-2/</loc>
		<lastmod>2009-04-09T08:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fa4a2aurobindo_pharma_wins_swiss_approval_for_bph-2/</loc>
		<lastmod>2009-04-09T08:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/23483novartis_wins_fda_approval_for_malaria-2/</loc>
		<lastmod>2009-04-09T09:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3e483merck_and_cardiome_sign_licensing_agreement_for_heart-2/</loc>
		<lastmod>2009-04-09T09:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/66485tomotherapy_appoints_new_board_membe-2/</loc>
		<lastmod>2009-04-09T09:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4148cmyriad_wins_ind_approval_for_new_cancer-2/</loc>
		<lastmod>2009-04-09T09:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a6482generex_wins_new_patent_in_mo-2/</loc>
		<lastmod>2009-04-09T09:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a0491cordex_to_collaborate_with_bgm_in_phase_ii_heart_failure_-2/</loc>
		<lastmod>2009-04-09T09:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0148csunwin_acquires_qufu_shengren_for_3_mi-2/</loc>
		<lastmod>2009-04-09T09:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/theravances_nda_for_pneumonia_drug_accepted_for_filing_by_fda_090409-2/</loc>
		<lastmod>2009-04-09T09:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a0493invatec_signs_distribution_agreement_with_cardiovascular_sy-2/</loc>
		<lastmod>2009-04-09T10:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/584b3dca_signs_clinical_grant_agreement_with_university_of_cinci-2/</loc>
		<lastmod>2009-04-09T10:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8748fmylan_and_scheringplough_settle_clarinex_patent_la-2/</loc>
		<lastmod>2009-04-09T10:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/654bborthocon_names_new_ceo_raises_25_million_in_series_b_fina-2/</loc>
		<lastmod>2009-04-09T10:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celsion_reports_encouraging_results_from_phase_i_breast_cancer_trial_090409-2/</loc>
		<lastmod>2009-04-09T10:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a7483ventus_medical_names_new_president_an-2/</loc>
		<lastmod>2009-04-09T10:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xtl_biopharmaceuticals_2008_net_loss_narrows_to_925m_090409-2/</loc>
		<lastmod>2009-04-09T10:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oxigene_initiates_phase_ibiia_study_of_vascular_disrupting_agent_090409-2/</loc>
		<lastmod>2009-04-09T11:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_files_two_regulatory_applications_for_tumor_drug_090409-2/</loc>
		<lastmod>2009-04-09T11:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vasomedical_wins_fda_clearance_for_biox_holter_monitor_and_analysis_software_090409-2/</loc>
		<lastmod>2009-04-09T11:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/reneuron_reports_positive_data_from_peripheral_arterial_disease_study_090409-2/</loc>
		<lastmod>2009-04-09T12:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wyeth_files_biologic_license_application_for_pneumonia_vaccine_090409-2/</loc>
		<lastmod>2009-04-09T12:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioniche_completes_recruitment_in_first_phase_iii_bladder_cancer_trial_090409-2/</loc>
		<lastmod>2009-04-09T12:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novabay_q4_net_loss_widens_to_15m_090409-2/</loc>
		<lastmod>2009-04-09T12:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sigmaaldrich_appoints_michael_kanan_as_vice_president_and_corporate_controller_090410-2/</loc>
		<lastmod>2009-04-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c54b2cardiodynamics_q1_net_loss_na-2/</loc>
		<lastmod>2009-04-10T06:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e748ecryocell_reports_q1_net_i-2/</loc>
		<lastmod>2009-04-10T06:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0c484sinovac_biotech_q4_net_income_increases_sli-2/</loc>
		<lastmod>2009-04-10T06:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/454a4johnson__johnson_to_axe_900-2/</loc>
		<lastmod>2009-04-10T06:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2a487takeda_to_reclaim_sales_rights_to_actos_from_-2/</loc>
		<lastmod>2009-04-10T07:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2b485golden_helix_and_spinco_biotech_sign_distribution_agre-2/</loc>
		<lastmod>2009-04-10T09:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bf480spineguard_raises_11_million_in_fina-2/</loc>
		<lastmod>2009-04-10T09:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/724bbcardiola_raises_2_million_in_fina-2/</loc>
		<lastmod>2009-04-10T09:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e9495monosol_rx_and_strativa_file_nda_for_ondansetron_orally_dissolving_film_-2/</loc>
		<lastmod>2009-04-10T09:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f64a6diamedica_wins_funding_from_national_research_council_of_c-2/</loc>
		<lastmod>2009-04-10T09:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/85491tcland_expression_names_new_board_m-2/</loc>
		<lastmod>2009-04-10T09:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/304a5auspex_makes_senior_management_ch-2/</loc>
		<lastmod>2009-04-10T09:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7a481cell_biosciences_raises_10_million_in_series_c_fina-2/</loc>
		<lastmod>2009-04-10T10:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f74adnatco_and_lupin_to_sell_generic_kidney-2/</loc>
		<lastmod>2009-04-10T10:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cc4bbmedtronic_completes_acquisition_of_core-2/</loc>
		<lastmod>2009-04-10T10:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/094a4marinus_secures_20_million_in_series_b_fina-2/</loc>
		<lastmod>2009-04-10T10:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5a48aacorda_names_new_vice_president_of_preclinical_develo-2/</loc>
		<lastmod>2009-04-10T10:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5f49dsenorx_launches_new_model_of_breast_biopsy_d-2/</loc>
		<lastmod>2009-04-10T10:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/854b7stemedica_opens_new_facility_in_switze-2/</loc>
		<lastmod>2009-04-10T10:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/864aemolecular_templates_raises_25_million_in_series_a_fina-2/</loc>
		<lastmod>2009-04-10T10:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arbor_vita_wins_fda_clearance_for_new_flu_test_130409-2/</loc>
		<lastmod>2009-04-13T06:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ondine_biopharma_signs_loi_with_js_dental_technologies_130409-2/</loc>
		<lastmod>2009-04-13T06:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kai_pharmaceuticals_initiates_enrollment_in_third_phase_iia_pain_trial_130409-2/</loc>
		<lastmod>2009-04-13T06:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/404abpfizer_names_new_vice_president_of_medical_affairs_for_oncology-2/</loc>
		<lastmod>2009-04-13T06:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/614a7sigmaaldrich_names_new_vice_president_and_corporate_contr-2/</loc>
		<lastmod>2009-04-13T07:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e74b7pfizer_likely_to_increase_stake_in_india-2/</loc>
		<lastmod>2009-04-13T07:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/104a0express_scripts_to_acquire_wellpoint_nextrx_subsidiaries_for_47_bi-2/</loc>
		<lastmod>2009-04-13T07:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/89490ucb_launches_new_dosage_strength_of_seizure-2/</loc>
		<lastmod>2009-04-13T07:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/schering_plough_wins_indian_approval_for_hepatitis_c_combination_therapy_130409-2/</loc>
		<lastmod>2009-04-13T07:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/244b9cooltouch_and_endolaser_settle_patent_infringement_la-2/</loc>
		<lastmod>2009-04-13T07:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/othera_reports_positive_interim_results_from_phase_ii_dry_amd_trial_130409-2/</loc>
		<lastmod>2009-04-13T07:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7f484raptor_pharmaceuticals_names_new_chief_medical_of-2/</loc>
		<lastmod>2009-04-13T07:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amarins_maa_for_huntingtons_drug_accepted_for_review_by_emea_130409-2/</loc>
		<lastmod>2009-04-13T08:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentech_withdraws_psoriasis_drug_from_us_market_130409-2/</loc>
		<lastmod>2009-04-13T08:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biostar_pharmaceuticals_2008_net_income_up_130409-2/</loc>
		<lastmod>2009-04-13T10:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medifocus_reports_positive_results_from_phase_ii_breast_cancer_treatment_study_130409-2/</loc>
		<lastmod>2009-04-13T10:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/paion_and_ergomed_report_encouraging_data_from_phase_iia_cancer_pain_trial_130409-2/</loc>
		<lastmod>2009-04-13T11:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lundbeck_fails_to_win_fda_panels_backing_for_broader_use_of_schizophrenia_drug_130409-2/</loc>
		<lastmod>2009-04-13T11:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alimeras_phase_iii_dme_trials_win_positive_review_from_dsmb_130409-2/</loc>
		<lastmod>2009-04-13T12:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kiadis_reports_encouraging_data_from_bone_marrow_transplantations_study_130409-2/</loc>
		<lastmod>2009-04-13T12:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/phadia_wins_fda_clearance_for_new_allergy_test_130409-2/</loc>
		<lastmod>2009-04-13T12:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tolera_wins_orphan_drug_designation_for_organ_transplant_rejection_drug_130409-2/</loc>
		<lastmod>2009-04-13T12:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thermogenesis_appoints_j_melville_engle_as_ceo_and_matthew_plavan_as_coo_090414-2/</loc>
		<lastmod>2009-04-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/array_biopharma_initiates_dosing_in_phase_i_diabetes_trial_140409-2/</loc>
		<lastmod>2009-04-14T03:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celldex_acquires_rights_to_immune_stimulatory_molecules_from_amgen_140409-2/</loc>
		<lastmod>2009-04-14T05:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chemgenex_secures_a10m_in_financing_140409-2/</loc>
		<lastmod>2009-04-14T05:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thallion_pharmaceuticals_q1_net_loss_decreases_to_324m_140409-2/</loc>
		<lastmod>2009-04-14T05:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/424bcizumi_bio_and_kyoto_university_partner_to_advance_ips_cell_techn-2/</loc>
		<lastmod>2009-04-14T06:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/91498viewray_raises_25_million_in_series_b_fina-2/</loc>
		<lastmod>2009-04-14T06:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c44b9aegis_and_phylogica_partner_to_deliver_peptide_drugs_through_intranasal_s-2/</loc>
		<lastmod>2009-04-14T06:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5049esun_pharma_wins_fda_approval_to_market_generic_roxicodone_ta-2/</loc>
		<lastmod>2009-04-14T06:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sinovac_biotech_q4_net_income_increases_slightly_to_24m_140409-2/</loc>
		<lastmod>2009-04-14T06:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/994bagvk_biosciences_and_excel_team_up_to_conduct_clinical_trials_in-2/</loc>
		<lastmod>2009-04-14T06:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f248cpharmeng_makes_corporate_ch-2/</loc>
		<lastmod>2009-04-14T07:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c74b7endologix_names_new_vice_president_of_global_mark-2/</loc>
		<lastmod>2009-04-14T07:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1e4bfangel_biotechnology_and_materia_medica_sign_manufacturing_con-2/</loc>
		<lastmod>2009-04-14T07:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xoft_wins_canadian_approval_for_axxent_electronic_brachytherapy_system_140409-2/</loc>
		<lastmod>2009-04-14T07:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/624babiomet_q3_net_loss_w-2/</loc>
		<lastmod>2009-04-14T07:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/suven_completes_phase_i_study_of_alzheimers_drug_140409-2/</loc>
		<lastmod>2009-04-14T08:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/glenmark_completes_phase_i_inflammatory_pain_trial_140409-2/</loc>
		<lastmod>2009-04-14T08:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/014bdprometheus_and_rosetta_genomics_sign_licensing_and_collaboration_agre-2/</loc>
		<lastmod>2009-04-14T09:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/22482redpath_integrated_pathology_names_ne-2/</loc>
		<lastmod>2009-04-14T09:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c34b9mylan_names_new_vice_president_of_global_business_develo-2/</loc>
		<lastmod>2009-04-14T09:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9c487epicept_names_new_board_m-2/</loc>
		<lastmod>2009-04-14T09:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e84b7cambrex_names_new_vice_president_general_counsel_and_secr-2/</loc>
		<lastmod>2009-04-14T09:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/884b5mckesson_launches_new_plasma_and_biologics-2/</loc>
		<lastmod>2009-04-14T09:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/55494optimer_wins_new_production_patent_for_antibiotic-2/</loc>
		<lastmod>2009-04-14T09:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c8482invitrogen_launches_new_cell_culture_solution_for_immunology_res-2/</loc>
		<lastmod>2009-04-14T09:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ac487neostem_raises_11_million_in_fina-2/</loc>
		<lastmod>2009-04-14T09:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioxells_overactive_bladder_trial_fails_endpoint_140409-2/</loc>
		<lastmod>2009-04-14T09:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9b483sciele_pharma_announces_fda_approval_of_benzyl_alcohol_loti-2/</loc>
		<lastmod>2009-04-14T09:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6e4a0misonix_signs_new_distribution_agreement_with_ekrio-2/</loc>
		<lastmod>2009-04-14T09:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d849csinobiopharma_signs_sales_contracts_for_skeletal_muscle_rel-2/</loc>
		<lastmod>2009-04-14T09:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8d491bedford_to_begin_shipping_fluconazole_injection_in_pvc_flexible_conta-2/</loc>
		<lastmod>2009-04-14T10:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3a4b3integra_lifesciences_names_new_board_m-2/</loc>
		<lastmod>2009-04-14T10:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/034bcbard_names_new_group_vice_pres-2/</loc>
		<lastmod>2009-04-14T10:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6d4behalozyme_names_ne-2/</loc>
		<lastmod>2009-04-14T10:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ff4a8transoma_medical_initiates_enrollment_in_atrial_fibrillation_detection_-2/</loc>
		<lastmod>2009-04-14T10:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/berlin_heart_wins_canadian_approval_for_cardiac_support_device_140409-2/</loc>
		<lastmod>2009-04-14T10:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2449bzenobia_completes_initial_phase_of_service_agreement_with_syn-2/</loc>
		<lastmod>2009-04-14T10:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/154b7xenoport_exercises_option_to_copromote_so-2/</loc>
		<lastmod>2009-04-14T10:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1a497oasmia_wins_orphan_drug_designation_for_ovarian_cancer-2/</loc>
		<lastmod>2009-04-14T10:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/daiichi_sankyo_files_patent_lawsuit_against_11_generics_companies_140409-2/</loc>
		<lastmod>2009-04-14T11:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/china_sky_one_medical_reports_net_income_of_69_million_for_q4_2008_090415-2/</loc>
		<lastmod>2009-04-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amdl_reports_gross_revenues_of_336_million_for_full_year_2008_090415-2/</loc>
		<lastmod>2009-04-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott_reports_net_earnings_of_14_billion_for_q1_2009_090415-2/</loc>
		<lastmod>2009-04-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomerica_reports_net_sales_of_14_million_for_q3_fiscal_2009_090415-2/</loc>
		<lastmod>2009-04-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cardiometabolic_support_network_uses_cisco_webex_for_online_meetings_150409-2/</loc>
		<lastmod>2009-04-14T20:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/19480biovex_initiates_phase_iii_melanoma_-2/</loc>
		<lastmod>2009-04-15T01:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a0490biosantes_licensee_azur_pharma_launches_menopause_drug_-2/</loc>
		<lastmod>2009-04-15T02:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/core_essence_wins_fda_approval_for_securus_suture_anchor_system_150409-2/</loc>
		<lastmod>2009-04-15T04:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomet_q3_net_loss_widens_to_4787m_150409-2/</loc>
		<lastmod>2009-04-15T05:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d94acimmunovaccine_technologies_forms_research_collaboration_with-2/</loc>
		<lastmod>2009-04-15T06:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/centocor_and_schering_plough_win_canadian_approval_for_arthritis_drug_150409-2/</loc>
		<lastmod>2009-04-15T06:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medtox_scientific_posts_revenues_of_206_million_in_q1_2009_090415-2/</loc>
		<lastmod>2009-04-15T06:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d648epharming_secures_e20_million_standby_equity_agreement_with_ya_g-2/</loc>
		<lastmod>2009-04-15T06:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b44bfcortex_q4_net_loss_decreases_sli-2/</loc>
		<lastmod>2009-04-15T06:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neostem_raises_11m_in_financing_150409-2/</loc>
		<lastmod>2009-04-15T07:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2f497johnson__johnson_q1_net_earnings_dec-2/</loc>
		<lastmod>2009-04-15T07:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cf48dsanofiaventis_to_acquire_bipar_sci-2/</loc>
		<lastmod>2009-04-15T07:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/384aekarl_storz_to_introduce_new_laparoscopic_surger-2/</loc>
		<lastmod>2009-04-15T07:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/104b2merck_and_santen_sign_licensing_agreement_for_ophthalmic-2/</loc>
		<lastmod>2009-04-15T07:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/934aeamerican_biotech_labs_wins_fda_approval_for_new_wound_care_gel_pr-2/</loc>
		<lastmod>2009-04-15T07:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ee4a7hairdx_and_biodue_sign_agreement_for_genetic_hair_loss-2/</loc>
		<lastmod>2009-04-15T07:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5e499virostatics_acquires_library_of_300_drug_compounds_from_university_of_-2/</loc>
		<lastmod>2009-04-15T07:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9748fmedicure_q3_net_loss_na-2/</loc>
		<lastmod>2009-04-15T07:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alpine_biomed_opens_new_manufacturing_facility_in_vietnam_150409-2/</loc>
		<lastmod>2009-04-15T07:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmacyclics_initiates_treatment_in_phase_i_lymphoma_trial_150409-2/</loc>
		<lastmod>2009-04-15T07:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/15486syntopix_signs_evaluation_agreement_with_consumer_healthcare-2/</loc>
		<lastmod>2009-04-15T08:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e04bfcell_therapeutics_initiates_rolling_nda_submission_for_lymphoma-2/</loc>
		<lastmod>2009-04-15T08:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/22491clinical_data_completes_sale_of_cogenics_to_beckman_co-2/</loc>
		<lastmod>2009-04-15T08:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7c48cribx_pharmaceuticals_wins_new_antibiotic_patent_in_-2/</loc>
		<lastmod>2009-04-15T08:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7748censemble_discovery_and_bristolmyers_squibb_form_rd_collabor-2/</loc>
		<lastmod>2009-04-15T08:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4a4a0osprey_initiates_dosing_in_phase_ib_nephropathy_-2/</loc>
		<lastmod>2009-04-15T08:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aa491cerus_and_belgian_red_cross_sign_contract_for_intercept_platelet_s-2/</loc>
		<lastmod>2009-04-15T09:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/284bdoxygen_biotherapeutics_signs_supply_agreement_with_ho-2/</loc>
		<lastmod>2009-04-15T09:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/664a2nmt_medical_names_new_president_an-2/</loc>
		<lastmod>2009-04-15T09:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nanobac_and_eureka_genomics_sign_merger_agreement_150409-2/</loc>
		<lastmod>2009-04-15T09:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fc48ftekmira_files_ind_for_phase_i_study_of_cholesterol-2/</loc>
		<lastmod>2009-04-15T09:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d24b5dendreons_phase_iii_prostate_cancer_trial_meets_primary_end-2/</loc>
		<lastmod>2009-04-15T09:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3d486medical_nutrition_names_new_vice_president_of_sales_and_mark-2/</loc>
		<lastmod>2009-04-15T09:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regenerx_enters_into_purchase_agreement_with_sigma_tau_groups_affiliate_150409-2/</loc>
		<lastmod>2009-04-15T09:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2c4a4angiotechs_partner_cook_medical_reports_encouraging_data_from_pad_-2/</loc>
		<lastmod>2009-04-15T09:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/26492vyteris_and_zealand_pharma_form_collabor-2/</loc>
		<lastmod>2009-04-15T10:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a24bfrexahn_to_obtain_855_million_in_financing_for_serdaxin_st-2/</loc>
		<lastmod>2009-04-15T10:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4b481intrinsic_therapeutics_wins_ce_mark_for_barricaid_anular_prost-2/</loc>
		<lastmod>2009-04-15T10:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3c4afbioms_obtains_positive_review_for_phase_iii_multiple_sclerosis_-2/</loc>
		<lastmod>2009-04-15T10:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3748egns_and_md_anderson_cancer_center_form_research_collabor-2/</loc>
		<lastmod>2009-04-15T10:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f54a4pacgen_names_new_board_m-2/</loc>
		<lastmod>2009-04-15T10:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4d49bmerck_serono_deploys_aegiss_discoverant_at_switzerland_manufacturing_fac-2/</loc>
		<lastmod>2009-04-15T10:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/634bflifecycle_pharmas_evp_and_chief_medical_officer_re-2/</loc>
		<lastmod>2009-04-15T10:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/154a5kaiser_names_new_svp_of_quality_and_care_delivery_excel-2/</loc>
		<lastmod>2009-04-15T10:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f5490thermogenesis_names_ne-2/</loc>
		<lastmod>2009-04-15T10:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d5497medtronic_wins_japanese_approval_for_talent_thoracic_stent_-2/</loc>
		<lastmod>2009-04-15T10:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/724a2cangene_names_new_vp_of_sales_marketing_and_business_develo-2/</loc>
		<lastmod>2009-04-15T10:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4448bludesi_launches_new_redfin_solo_image_analysis_sof-2/</loc>
		<lastmod>2009-04-15T10:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c84acnatco_pharma_and_dr_reddys_team_up_for_oncology_-2/</loc>
		<lastmod>2009-04-15T10:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ppd_acquires_magen_biosciences_for_145m_150409-2/</loc>
		<lastmod>2009-04-15T11:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genta_completes_enrollment_in_phase_iii_melanoma_trial_150409-2/</loc>
		<lastmod>2009-04-15T11:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/comparativeeffectiveness_research_on_medical_procedures_worries_device_drug_makers_090415-2/</loc>
		<lastmod>2009-04-15T11:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cerapedics_secures_15m_in_series_b_financing_150409-2/</loc>
		<lastmod>2009-04-15T11:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cardiodynamics_q1_net_loss_narrows_to_146m_150409-2/</loc>
		<lastmod>2009-04-15T11:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/millipore_and_novozymes_launch_new_cell_culture_supplement_150409-2/</loc>
		<lastmod>2009-04-15T12:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/orcrist_bio_wins_european_approval_for_phase_i_study_of_hyaluronan_formulation_150409-2/</loc>
		<lastmod>2009-04-15T12:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/peregrine_wins_new_us_patent_150409-2/</loc>
		<lastmod>2009-04-15T12:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/athera_signs_agreements_with_german_and_uk_distributors_for_new_cardiovascular_biomarker_090416-2/</loc>
		<lastmod>2009-04-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytocore_signs_agreement_with_amsino_090416-2/</loc>
		<lastmod>2009-04-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/baxter_reports_net_income_of_516_million_for_q1_2009_090416-2/</loc>
		<lastmod>2009-04-16T11:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/meridian_bioscience_reports_net_earnings_of_72_million_for_q2_fiscal_2009_090416-2/</loc>
		<lastmod>2009-04-16T11:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/simbionix_and_jj_sign_distribution_agreement_for_russia_and_the_cis_countries_090417-2/</loc>
		<lastmod>2009-04-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5f4a6xenomics_names_new_board_cha-2/</loc>
		<lastmod>2009-04-17T03:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/69482orthofix_signs_new_agreement_with_mba_-2/</loc>
		<lastmod>2009-04-17T03:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5e494synageva_raises_30_million_in_equity_fina-2/</loc>
		<lastmod>2009-04-17T03:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1b4babaxter_signs_distribution_agreement_with_-2/</loc>
		<lastmod>2009-04-17T03:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/304b6merit_medical_wins_fda_clearance_for_proguide_chronic_dialysis_cat-2/</loc>
		<lastmod>2009-04-17T03:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fc4a3idaho_technology_and_microbiology_international_sign_distribution_agre-2/</loc>
		<lastmod>2009-04-17T04:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b54acathera_signs_agreements_with_asbach_medical_and_oxford_biosy-2/</loc>
		<lastmod>2009-04-17T04:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/32480resolvyx_names_new_chief_scientific_of-2/</loc>
		<lastmod>2009-04-17T04:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/traversa_therapeutics_raises_5m_in_series_b_financing_170409-2/</loc>
		<lastmod>2009-04-17T05:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dph_urges_residents_to_be_tested_for_stds_090417-2/</loc>
		<lastmod>2009-04-17T05:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c34baintegra_to_launch_new_dermal_regeneration_template_in_-2/</loc>
		<lastmod>2009-04-17T05:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0d4b1recordati_launches_hypertension_drug_in_f-2/</loc>
		<lastmod>2009-04-17T05:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b5483atcor_medical_signs_new_clinical_trial_cont-2/</loc>
		<lastmod>2009-04-17T05:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/354aamedquist_names_ne-2/</loc>
		<lastmod>2009-04-17T05:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9f4bccytocore_signs_distribution_agreement_with_amsino_internat-2/</loc>
		<lastmod>2009-04-17T05:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f2495china_medicine_wins_distribution_rights_for_liao_yuans_surgical_sol-2/</loc>
		<lastmod>2009-04-17T05:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/40495tigris_pharmaceuticals_names_new_cha-2/</loc>
		<lastmod>2009-04-17T05:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nih_publishes_draft_guidelines_on_human_stem_cell_research_090417-2/</loc>
		<lastmod>2009-04-17T05:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f4497sirion_reports_positive_results_from_interim_analysis_of_phase_ii_amd_-2/</loc>
		<lastmod>2009-04-17T05:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva_wins_fda_approval_for_generic_birth_control_drug_170409-2/</loc>
		<lastmod>2009-04-17T05:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/994b1adeona_names_new_president_for_healthmine_subsi-2/</loc>
		<lastmod>2009-04-17T06:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/134bdminnow_medical_wins_ce_mark_for_new_disposable_cat-2/</loc>
		<lastmod>2009-04-17T06:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/064b0ventirx_initiates_phase_i_allergic_rhinitis_-2/</loc>
		<lastmod>2009-04-17T06:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7b4b4novadaq_obtains_1_million_milestone_payment_from_intuitive_sur-2/</loc>
		<lastmod>2009-04-17T06:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/914bcparadigm_medical_signs_distribution_agreement_wit-2/</loc>
		<lastmod>2009-04-17T06:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/99494genetic_immunity_initiates_phase_ii_study_of_hiv_vaccine_-2/</loc>
		<lastmod>2009-04-17T06:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/45488imaging_diagnostic_systems_renews_distribution_agreement_with_ed-2/</loc>
		<lastmod>2009-04-17T06:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3c482waters_and_university_of_warwick_sign_research_agre-2/</loc>
		<lastmod>2009-04-17T06:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/28497intelgenx_names_new_board_m-2/</loc>
		<lastmod>2009-04-17T06:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d5485lycera_raises_36_million_in_series_a_fina-3/</loc>
		<lastmod>2009-04-17T06:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eb4bedjos_chattanooga_division_wins_fda_clearance_for_shortwave_diathermy_d-3/</loc>
		<lastmod>2009-04-17T07:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c6487cangene_signs_supply_agreement_with_us_department_of_de-3/</loc>
		<lastmod>2009-04-17T07:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8e48eaetna_signs_agreement_with_mayo_clinic_fl-2/</loc>
		<lastmod>2009-04-17T07:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/714b9alnara_pharmaceuticals_names_new_chief_business_of-2/</loc>
		<lastmod>2009-04-17T07:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ea4a6simbionix_and_johnson__johnsons_subsidiary_sign_distribution_agre-2/</loc>
		<lastmod>2009-04-17T07:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5d4b0biosphere_medical_signs_distribution_agreement_with_nippon_k-2/</loc>
		<lastmod>2009-04-17T08:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genomic_healthscancer_assay_study_meets_primary_endpoint_170409-2/</loc>
		<lastmod>2009-04-17T08:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tsca_reform_political_changes_are_hot_topics_at_globalchem_2009_170409-2/</loc>
		<lastmod>2009-04-17T08:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ppg_reports_q1_net_loss_of_111m_170409-2/</loc>
		<lastmod>2009-04-17T08:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kowa_pharmaceuticals_america_to_divest_diclofenac_assets_170409-2/</loc>
		<lastmod>2009-04-17T08:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/federal_government_unveils_guidelines_for_broader_stem_cell_research_090417-2/</loc>
		<lastmod>2009-04-17T09:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8348ebaxter_q1_net_income_-2/</loc>
		<lastmod>2009-04-17T09:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/094b6biogen_idec_q1_net_income_incr-2/</loc>
		<lastmod>2009-04-17T09:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/784b7cas_medical_systems_launches_foresight_nonadhesive_small_se-2/</loc>
		<lastmod>2009-04-17T10:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/024b8biogen_idec_wins_approval_for_high_titer_production_of_multiple_sclerosis-2/</loc>
		<lastmod>2009-04-17T10:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_and_medivation_to_initiates_phase_iii_trial_for_alzheimers_disease_170409-2/</loc>
		<lastmod>2009-04-17T10:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/proposed_nih_stem_cell_guidelines_dismay_stanford_researcher_090417-2/</loc>
		<lastmod>2009-04-17T11:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/experts_share_risk_management_predictions_at_globalchem_2009_170409-2/</loc>
		<lastmod>2009-04-17T11:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec_phase_ii_smoking_cessation_study_fails_endpoint_170409-2/</loc>
		<lastmod>2009-04-17T11:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quinnova_pharmaceuticals_wins_fda_clearance_for_neosalus_cream_170409-2/</loc>
		<lastmod>2009-04-17T12:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f64b7macusight_selects_etrialss_edc_and_ivr_solu-2/</loc>
		<lastmod>2009-04-19T12:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/response_reports_preliminary_loss_of_cad2526_million_for_q1_fiscal_2009_090420-2/</loc>
		<lastmod>2009-04-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dph_launches_new_colorectal_cancer__genetic_testing_resource_090420-2/</loc>
		<lastmod>2009-04-20T04:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mednax_implements_courions_enterprise_suite_200409-2/</loc>
		<lastmod>2009-04-20T05:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/achillion_wins_new_us_patent_200409-2/</loc>
		<lastmod>2009-04-20T05:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/applied_dna_sciences_opens_authentication_laboratory_in_uk_200409-2/</loc>
		<lastmod>2009-04-20T06:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/somanetics_wins_fda_clearance_to_expand_labeling_for_invos_oximeter_200409-2/</loc>
		<lastmod>2009-04-20T06:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_and_pfizer_to_establish_new_hiv_company_200409-2/</loc>
		<lastmod>2009-04-20T07:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biolases_ezlase_wins_fda_clearance_for_pain_therapy_and_relief_200409-2/</loc>
		<lastmod>2009-04-20T07:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/globeimmune_initiates_phase_i_metastatic_cancer_trial_200409-2/</loc>
		<lastmod>2009-04-20T07:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/baxter_q1_net_income_rises_to_518m_200409-2/</loc>
		<lastmod>2009-04-20T08:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d5491ats_medical_wins_japanese_approval_for_new_mechanical_heart_-2/</loc>
		<lastmod>2009-04-20T08:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/894b6cardiovascular_systems_makes_senior_management_ch-2/</loc>
		<lastmod>2009-04-20T08:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a14b1covidien_introduces_new_alarm_management_s-2/</loc>
		<lastmod>2009-04-20T08:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/galeas_nutraplete_approved_for_medicaid_reimbursement_in_key_market_states_200409-2/</loc>
		<lastmod>2009-04-20T08:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clavis_pharma_initiates_phase_ii_pancreatic_cancer_trial_200409-2/</loc>
		<lastmod>2009-04-20T08:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ac491lilly_names_new_senior_vice_president_of_human_reso-2/</loc>
		<lastmod>2009-04-20T08:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/694behansen_medical_prices_public_offering_at_-2/</loc>
		<lastmod>2009-04-20T08:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ae4a6galapagos_and_merck_form_all-2/</loc>
		<lastmod>2009-04-20T09:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/stemcells_licenses_gene_insertion_technology_to_major_pharma_company_200409-2/</loc>
		<lastmod>2009-04-20T09:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/304b8patheon_expands_toronto_manufacturing_fac-2/</loc>
		<lastmod>2009-04-20T09:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/be48avirionyx_changes_name_to_innate_therape-2/</loc>
		<lastmod>2009-04-20T09:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7e4a8gilead_sciences_completes_acquisition_of_cv_therape-2/</loc>
		<lastmod>2009-04-20T09:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b8482hst_global_signs_loi_to_acquire_treatment_fac-2/</loc>
		<lastmod>2009-04-20T09:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d249dmersana_reports_positive_results_from_preclinical_studies_of_anticancer-2/</loc>
		<lastmod>2009-04-20T09:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/16482medlink_signs_agreement_with_zwangerp-2/</loc>
		<lastmod>2009-04-20T09:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8a4b9red_reef_laboratories_acquires_impact_fusion_internatio-2/</loc>
		<lastmod>2009-04-20T09:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c8492siro_and_advanced_clinical_trial_solutions_form_all-2/</loc>
		<lastmod>2009-04-20T09:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4b48eactavis_reintroduces_oxycodone_-2/</loc>
		<lastmod>2009-04-20T10:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b3499chiltern_acquires_v-2/</loc>
		<lastmod>2009-04-20T10:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c948emedicis_obtains_new_notice_of_allowance_for_acne-2/</loc>
		<lastmod>2009-04-20T10:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/144bechemdiv_group_acquires_prud-2/</loc>
		<lastmod>2009-04-20T10:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b44a8shanghai_chempartner_and_skk_form_all-2/</loc>
		<lastmod>2009-04-20T10:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dd4b7intelgenx_reports_positive_results_from_study_of_new_antihypertensive_pr-2/</loc>
		<lastmod>2009-04-20T10:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/combimatrix_names_karine_hovanes_as_laboratory_director_for_its_cmdx_subsidiary_090420-2/</loc>
		<lastmod>2009-04-20T10:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a2486hadasit_licenses_oral_immune_modulation_technology_to_im-2/</loc>
		<lastmod>2009-04-20T10:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a0480cmed_names_new_global_head_of_biome-2/</loc>
		<lastmod>2009-04-20T10:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2d484illumina_and_agilent_sign_comarketing_agre-2/</loc>
		<lastmod>2009-04-20T10:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ncis_plan_to_accelerate_cancer_research_announced_090420-2/</loc>
		<lastmod>2009-04-20T10:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/adeona_to_acquire_colwell_clinical_laboratories_200409-2/</loc>
		<lastmod>2009-04-20T11:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sud_chemie_to_acquire_basfs_china_syngas_catalysts_site_200409-2/</loc>
		<lastmod>2009-04-20T12:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/intuitive_surgical_q1_net_income_shrinks_200409-2/</loc>
		<lastmod>2009-04-20T14:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/can_fite_to_initiate_phase_iii_liver_cancer_trial_200409-2/</loc>
		<lastmod>2009-04-20T14:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vions_nda_for_cancer_drug_accepted_for_review_by_fda_200409-2/</loc>
		<lastmod>2009-04-20T14:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/illumina_posts_net_income_of_188_million_for_q1_2009_090421-2/</loc>
		<lastmod>2009-04-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e048fpatient_safety_technologies_q4_net_loss_na-2/</loc>
		<lastmod>2009-04-21T01:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dendreon_reports_encouraging_data_from_phase_iii_prostate_cancer_trial_210409-2/</loc>
		<lastmod>2009-04-21T05:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/icagen_reports_promising_data_from_phase_i_study_of_epilepsy_and_pain_drug_210409-2/</loc>
		<lastmod>2009-04-21T06:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead_sciences_initiates_phase_ii_hiv_1_infection_trial_210409-2/</loc>
		<lastmod>2009-04-21T06:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_and_medivation_initiate_phase_iii_alzheimers_trial_200409-2/</loc>
		<lastmod>2009-04-21T06:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d44b5galapagos_and_opsona_initiate_drug_discovery_collabor-2/</loc>
		<lastmod>2009-04-21T07:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0a483boston_scientific_reports_q1_net-2/</loc>
		<lastmod>2009-04-21T07:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1349bactelion_q1_net_inco-3/</loc>
		<lastmod>2009-04-21T07:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/644b6sanofiaventis_to_invest_90_million_in_-3/</loc>
		<lastmod>2009-04-21T07:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/87494sagia_and_emaar_sign_mou_with_sanofiav-3/</loc>
		<lastmod>2009-04-21T07:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/osiris_completes_enrollment_in_phase_iii_graft_versus_host_disease_trial_210409-2/</loc>
		<lastmod>2009-04-21T07:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/china_biologic_products_acquires_90_stake_in_chongqing_dalin_210409-2/</loc>
		<lastmod>2009-04-21T07:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7a491seegene_introduces_new_diagnostic_test_for_menin-2/</loc>
		<lastmod>2009-04-21T07:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6c49echina_aoxing_wins_gmp_certification_for_new_production_fac-2/</loc>
		<lastmod>2009-04-21T08:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/81499vectura_obtains_e25_million_milestone_pa-2/</loc>
		<lastmod>2009-04-21T08:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/allos_therapeutics_reports_encouraging_data_from_cancer_trial_210409-2/</loc>
		<lastmod>2009-04-21T08:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/epa_to_regulate_nanomaterials_210409-2/</loc>
		<lastmod>2009-04-21T08:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/93494pharmerica_names_new_executive_vice_president_of_opera-2/</loc>
		<lastmod>2009-04-21T08:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/414a8halo_pharmaceutical_names_new_chief_scientific_of-2/</loc>
		<lastmod>2009-04-21T08:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/314a5mpex_pharmaceuticals_names_new_chief_business_of-2/</loc>
		<lastmod>2009-04-21T08:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/radnet_acquires_10_imaging_centers_from_medical_resources_210409-2/</loc>
		<lastmod>2009-04-21T08:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/df480atcor_medical_wins_new_clinical_trial_con-2/</loc>
		<lastmod>2009-04-21T09:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b0489elusys_initiates_second_phase_i_trial_of_anthrax_anti-2/</loc>
		<lastmod>2009-04-21T09:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2b485expression_pathology_raises_additional_65_million_in_fina-2/</loc>
		<lastmod>2009-04-21T09:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/32499welichem_initiates_toxicology_studies_of_antiinflammatory-2/</loc>
		<lastmod>2009-04-21T09:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/51497molecularmd_and_mayo_clinic_sign_sublicensing_agre-2/</loc>
		<lastmod>2009-04-21T09:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e64a3qiagen_and_cnci_team_up_to_establish_cancer_screening_program_in_-2/</loc>
		<lastmod>2009-04-21T09:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/444a2smartgene_and_virco_lab_form_collabor-3/</loc>
		<lastmod>2009-04-21T09:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b54aepolymer_technology_systems_launches_new_connectivity_software_sol-3/</loc>
		<lastmod>2009-04-21T09:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/104a6integrameds_subsidiary_opens_new_facility_in-3/</loc>
		<lastmod>2009-04-21T10:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/894a6amnis_wins_new_patent_for_diagnostic_cell_im-2/</loc>
		<lastmod>2009-04-21T10:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/62493expression_analysis_and_raindance_technologies_form_research_collabor-2/</loc>
		<lastmod>2009-04-21T10:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/774b9amira_initiates_phase_i_trial_of_antiinflammatory_and_allergic-2/</loc>
		<lastmod>2009-04-21T10:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/81488sanofiaventis_launches_new_insulin_delivery_device_-2/</loc>
		<lastmod>2009-04-21T10:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e3488gsk_launches_weight_loss_drug_in_e-2/</loc>
		<lastmod>2009-04-21T10:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1049dmotorika_raises_195_million_in_new_fina-2/</loc>
		<lastmod>2009-04-21T10:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nucletron_reports_net_sales_of_165_million_for_yearend_2008_090422-2/</loc>
		<lastmod>2009-04-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quidel_posts_net_loss_of_28_million_for_q1_2009_090422-2/</loc>
		<lastmod>2009-04-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/axisshield_posts_pat_of_gbp44_million_for_2008_090422-2/</loc>
		<lastmod>2009-04-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/misonix_signs_five_year_distribution_agreement_with_dtl_for_romania_and_bulgaria_090422-2/</loc>
		<lastmod>2009-04-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b0494lorus_reports_encouraging_preclinical_data_from_cancer_-2/</loc>
		<lastmod>2009-04-22T02:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/594aaariad_reports_encouraging_preclinical_data_from_cancer_st-2/</loc>
		<lastmod>2009-04-22T03:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e44bacovidien_files_patent_infringement_lawsuit_against_-2/</loc>
		<lastmod>2009-04-22T05:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/microline_pentax_acquires_starion_instruments_220409-2/</loc>
		<lastmod>2009-04-22T05:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ef481iscience_raises_205_million_in_series_f_fina-2/</loc>
		<lastmod>2009-04-22T05:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7f497wound_care_innovations_and_qx_partners_sign_agre-2/</loc>
		<lastmod>2009-04-22T06:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8f49dgenerex_signs_agreement_with_immune_tolerance_network_for_diabetes-2/</loc>
		<lastmod>2009-04-22T06:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dc488davita_names_new_senior_vice_president_of_federal_legislative_af-2/</loc>
		<lastmod>2009-04-22T06:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boston_scientific_reports_q1_net_loss_of_13m_220409-2/</loc>
		<lastmod>2009-04-22T06:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a44b9ppd_opens_new_facility_in_-2/</loc>
		<lastmod>2009-04-22T06:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/peregrine_reports_positive_data_from_phase_ii_lung_cancer_trial_220409-2/</loc>
		<lastmod>2009-04-22T06:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8d497bioalliance_pharma_reports_encouraging_results_form_melanoma_-2/</loc>
		<lastmod>2009-04-22T06:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/334aabiopath_signs_clinical_support_agreement_with_acor-2/</loc>
		<lastmod>2009-04-22T06:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/qrxpharma_completes_comparative_study_for_dual_opioid_pain_therapy_220409-2/</loc>
		<lastmod>2009-04-22T06:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a248eroche_nimblegen_and_sigmaaldrich_form_collabor-2/</loc>
		<lastmod>2009-04-22T06:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/actelion_q1_net_income_increased_to_chf1021m_220409-2/</loc>
		<lastmod>2009-04-22T06:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5c485pharmos_raises_18_million_in_private_plac-2/</loc>
		<lastmod>2009-04-22T06:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/11493huya_bioscience_and_abbott_form_all-2/</loc>
		<lastmod>2009-04-22T06:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/524a5merck_medarex_and_mbl_sign_licensing_agreem-2/</loc>
		<lastmod>2009-04-22T07:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c74a5vantia_therapeutics_names_new_head_of_regulatory_af-2/</loc>
		<lastmod>2009-04-22T07:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biolex_initiates_dosing_in_phase_iib_hepatitis_trial_220409-2/</loc>
		<lastmod>2009-04-22T07:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8c4aebiomerica_wins_ce_mark_for_new_kidney-2/</loc>
		<lastmod>2009-04-22T07:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alnylam_obtains_notice_of_allowance_for_new_european_patent_220409-2/</loc>
		<lastmod>2009-04-22T07:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/34492scn_extends_collaboration_with_vital_life_internat-2/</loc>
		<lastmod>2009-04-22T07:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f84b0daiichi_sankyo_wins_approval_for_new_formulations_of_antibiotic-2/</loc>
		<lastmod>2009-04-22T07:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9949eppd_completes_acquisition_of_-2/</loc>
		<lastmod>2009-04-22T07:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/spepharm_launches_mugard_and_xerotin_in_europe_220409-2/</loc>
		<lastmod>2009-04-22T07:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tolarex_wins_israeli_approval_to_initiate_phase_iiia_gvhd_study_220409-2/</loc>
		<lastmod>2009-04-22T07:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi_aventis_to_invest_90m_in_china_220409-2/</loc>
		<lastmod>2009-04-22T08:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perkinelmer_introduces_new_series_of_immunoassay_kits_220409-2/</loc>
		<lastmod>2009-04-22T09:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/impax_pharmaceuticals_initiates_phase_iii_parkinsons_trial_220409-2/</loc>
		<lastmod>2009-04-22T09:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_serono_introduces_kuvan_in_europe_220409-2/</loc>
		<lastmod>2009-04-22T10:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medarex_reports_encouraging_preliminary_data_from_phase_i_lymphoma_trial_220409-2/</loc>
		<lastmod>2009-04-22T10:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_to_acquire_stiefel_for_36_billion_220409-2/</loc>
		<lastmod>2009-04-22T10:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genzyme_posts_net_income_of_1955_million_for_q1_2009_090422-2/</loc>
		<lastmod>2009-04-22T10:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmasset_terminates_phase_iii_hepatitis_b_studies_220409-2/</loc>
		<lastmod>2009-04-22T10:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nanobio_initiates_phase_i_influenza_vaccine_trial_220409-2/</loc>
		<lastmod>2009-04-22T10:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thermo_fisher_posts_net_income_of_1489_million_for_q1_2009_090423-2/</loc>
		<lastmod>2009-04-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cepheid_posts_net_loss_of_74_million_revenues_of_448_million_for_q1_2009_090423-2/</loc>
		<lastmod>2009-04-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen_reports_profit_of_102_billion_in_q1_2009_090423-2/</loc>
		<lastmod>2009-04-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/accumetrics_announces_uk_distribution_agreement_with_elitech_090423-2/</loc>
		<lastmod>2009-04-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sigmaaldrich_reports_net_income_of_844_million_for_q1_2009_090423-2/</loc>
		<lastmod>2009-04-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/patient_safety_technologies_q4_net_loss_narrows_to_630000_230409-2/</loc>
		<lastmod>2009-04-23T05:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/614bdgpc_biotech_reports_encouraging_preclinical_results_from_cancer_-2/</loc>
		<lastmod>2009-04-23T05:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2e4b6haemonetics_acquires_neoteric_techn-2/</loc>
		<lastmod>2009-04-23T05:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bc4a8biovail_names_new_vp_of_us_commercial_operations_for_bta_pharmaceut-2/</loc>
		<lastmod>2009-04-23T05:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/transave_completes_enrollment_in_phase_ii_bronchiectasis_trial_230409-2/</loc>
		<lastmod>2009-04-23T05:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentechs_phase_iiicancer_trial_fails_primary_endpoint_230409-2/</loc>
		<lastmod>2009-04-23T06:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fd490orthofix_expands_supply_contract_with_nov-2/</loc>
		<lastmod>2009-04-23T06:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alkermes_completes_enrollment_in_phase_iii_opioid_dependence_study_230409-2/</loc>
		<lastmod>2009-04-23T06:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/784bctakeda_discontinues_development_of_diabetes-2/</loc>
		<lastmod>2009-04-23T07:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmos_raises_18m_in_private_placement_230409-2/</loc>
		<lastmod>2009-04-23T07:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/264b7mimedx_wins_fda_clearance_for_paradis_vaso_shield_d-2/</loc>
		<lastmod>2009-04-23T07:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/isotechnika_reports_positive_data_from_kidney_transplant_trial_230409-2/</loc>
		<lastmod>2009-04-23T07:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f94a2entellus_medical_wins_new_patent_for_finess_sinus_trea-2/</loc>
		<lastmod>2009-04-23T07:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e8482covidien_introduces_sils_port_multiple_instrument_access-2/</loc>
		<lastmod>2009-04-23T07:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7a487stellar_pharmaceuticals_names_new_board_m-2/</loc>
		<lastmod>2009-04-23T07:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ff4bfhalo_pharmaceutical_raises_146_million_in_fina-2/</loc>
		<lastmod>2009-04-23T07:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/564b4phase_forward_acquires_waban_software_for_14_mi-2/</loc>
		<lastmod>2009-04-23T07:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nymox_wins_approval_to_initiate_phase_iii_bph_trials_230409-2/</loc>
		<lastmod>2009-04-23T07:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1949enovabay_signs_agreement_to_develop_aganocide_comp-2/</loc>
		<lastmod>2009-04-23T07:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0b48emisonix_signs_new_distribution_agreement_dtl_me-2/</loc>
		<lastmod>2009-04-23T07:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/circassia_initiates_phase_ii_asthma_trial_230409-2/</loc>
		<lastmod>2009-04-23T07:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/304b1sloning_names_new_vice_president_of_commercial_opera-2/</loc>
		<lastmod>2009-04-23T08:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dendreon_initiates_enrollment_in_phase_i_cancer_trial_230409-2/</loc>
		<lastmod>2009-04-23T08:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medicure_q3_net_loss_narrows_to_c364m_230409-2/</loc>
		<lastmod>2009-04-23T09:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novagali_pharma_completes_new_phase_ii_dry_eye_trial_230409-2/</loc>
		<lastmod>2009-04-23T09:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomerieux_posts_net_sales_of_eur1669_million_for_q1_2009_090423-2/</loc>
		<lastmod>2009-04-23T09:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomarin_initiates_phase_iii_lysosomal_storage_disorder_trial_230409-2/</loc>
		<lastmod>2009-04-23T10:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/par_pharmaceutical_signs_settlement_agreement_with_reliant_230409-2/</loc>
		<lastmod>2009-04-23T10:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi_pasteur_initiates_dengue_vaccine_studies_in_singapore_and_vietnam_230409-2/</loc>
		<lastmod>2009-04-23T10:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lilly_q1_net_income_rises_23_230409-2/</loc>
		<lastmod>2009-04-23T11:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vasogen_appoints_dr_eldon_smith_as_new_chairman_090424-2/</loc>
		<lastmod>2009-04-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d64bddatatrak_signs_agreement_with_key-2/</loc>
		<lastmod>2009-04-24T00:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ef4b3avalon_signs_provider_agreement_with_lee_memorial_health_s-2/</loc>
		<lastmod>2009-04-24T00:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8c49cdr_willmar_schwabe_pharmaceuticals_acquires_dr_peithner_ho-2/</loc>
		<lastmod>2009-04-24T00:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6c48bpfizer_and_medicines_for_malaria_venture_sign_agre-2/</loc>
		<lastmod>2009-04-24T01:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1c49dbioalliance_pharma_reports_encouraging_results_from_colorectal_cancer_-2/</loc>
		<lastmod>2009-04-24T01:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d64a9telesso_technologies_initiates_headtohead_catheter_clinical_-2/</loc>
		<lastmod>2009-04-24T01:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/684aesandoz_wins_canadian_approval_for_omnitrope_growth_ho-2/</loc>
		<lastmod>2009-04-24T02:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ce4baacelrx_initiates_phase_ii_cancer_breakthrough_pain_-2/</loc>
		<lastmod>2009-04-24T02:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a04bfmetabolex_names_new_board_m-2/</loc>
		<lastmod>2009-04-24T02:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7b4b0interna_technologies_and_radboud_unmc_sign_research_agre-2/</loc>
		<lastmod>2009-04-24T02:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/08489fluke_acquires_hawk_ir_internat-2/</loc>
		<lastmod>2009-04-24T02:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8649delan_and_transition_therapeutics_win_new_patent_for_alzheimers_trea-2/</loc>
		<lastmod>2009-04-24T03:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/154b7opko_health_names_new_board_m-2/</loc>
		<lastmod>2009-04-24T03:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a2495targacept_initiates_phase_ii_hypertension_-2/</loc>
		<lastmod>2009-04-24T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5c4a1watson_files_two_andas_for_generic_mu-2/</loc>
		<lastmod>2009-04-24T04:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6149cnuvasive_to_acquire_cerv-2/</loc>
		<lastmod>2009-04-24T04:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/70499hansen_medical_raises_351_million_in_public_off-2/</loc>
		<lastmod>2009-04-24T06:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3b4a7bolton_medical_introduces_new_relay_plus_delivery_s-2/</loc>
		<lastmod>2009-04-24T06:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c24a7emergent_announces_launch_of_phase_iib_tuberculosis_vaccine_-2/</loc>
		<lastmod>2009-04-24T06:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8d4b6corventis_launches_new_mobile_patient_management_s-2/</loc>
		<lastmod>2009-04-24T06:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3c49bnovartis_q1_net_income_decrease-2/</loc>
		<lastmod>2009-04-24T06:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f1499seattle_genetics_q1_net_loss_incr-2/</loc>
		<lastmod>2009-04-24T06:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/144bdidera_wins_new_pa-2/</loc>
		<lastmod>2009-04-24T06:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6a49esucampo_acquires_rights_to_rtus_ophthalmic_drug_for_us_and_c-2/</loc>
		<lastmod>2009-04-24T06:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ed4a9addrenex_reports_positive_results_from_second_phase_iii_adhd_-2/</loc>
		<lastmod>2009-04-24T07:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5c4a2novo_nordisk_obtains_eu_positive_opinion_for_diabetes_dru-2/</loc>
		<lastmod>2009-04-24T07:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/db4a1astrazeneca_wins_eu_positive_opinion_for_new_lung_cancer-2/</loc>
		<lastmod>2009-04-24T07:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7a4b9amgen_q1_net_income-2/</loc>
		<lastmod>2009-04-24T07:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7c498altheadx_launches_new_affymetrix_dmet_genotyping_microarray_se-2/</loc>
		<lastmod>2009-04-24T07:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b4b0medx_health_opens_distribution_center_in_nether-2/</loc>
		<lastmod>2009-04-24T08:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fb493gilead_sciences_q1_net_inco-2/</loc>
		<lastmod>2009-04-24T09:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3a4a5merck__co_q1_net_income_d-2/</loc>
		<lastmod>2009-04-24T09:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ca4a4scheringplough_q1_net_income_s-2/</loc>
		<lastmod>2009-04-24T09:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b84a1biocodex_names_vice_president_and_managing_director_of_us_opera-2/</loc>
		<lastmod>2009-04-24T10:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a4489acorda_resubmits_nda_for_multiple_sclerosis_th-2/</loc>
		<lastmod>2009-04-24T10:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d9490gtx_names_new_executive_director_of_medical_affairs_and_clinical_develo-2/</loc>
		<lastmod>2009-04-24T10:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9e486icagen_completes_enrollment_in_phase_ii_asthma_-2/</loc>
		<lastmod>2009-04-24T10:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8d4a2cangene_wins_canadian_approval_for_second_indication_of_hepatitis-2/</loc>
		<lastmod>2009-04-24T11:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/proposed_changes_to_2010_iur_reporting_at_globalchem_240409-2/</loc>
		<lastmod>2009-04-24T11:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d04a6amorfix_and_biomosaics_partner_to_develop_blood_test_for_liver_c-2/</loc>
		<lastmod>2009-04-24T11:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8e49fglaxosmithkline_q1_profit-2/</loc>
		<lastmod>2009-04-24T11:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9a49fdfb_names_new_vp_of_business_development_and_corporate_fi-2/</loc>
		<lastmod>2009-04-24T11:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7c4b8opko_health_wins_new_us_p-2/</loc>
		<lastmod>2009-04-24T11:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ca4aasri_surgical_names_new_senior_vice_president_of_opera-2/</loc>
		<lastmod>2009-04-24T11:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e54bdchina_sky_one_medical_wins_approvals_for_geranium_ointment_and_musk_lin-2/</loc>
		<lastmod>2009-04-24T11:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9e485asterand_and_abcam_sign_collaborative_agre-2/</loc>
		<lastmod>2009-04-24T11:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/514b4alethia_biotherapeutics_raises_22_million_in_fina-2/</loc>
		<lastmod>2009-04-24T11:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eastman_chemical_reports_loss_in_revenues_240409-2/</loc>
		<lastmod>2009-04-24T12:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8748eanadys_reports_encouraging_results_from_phase_ib_hepatitis_-2/</loc>
		<lastmod>2009-04-27T00:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/104bbscheringplough_reports_encouraging_results_from_phase_ii_hepatitis_-2/</loc>
		<lastmod>2009-04-27T00:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/174b6salix_reports_encouraging_results_from_phase_iii_hepatic_encephalopathy_-2/</loc>
		<lastmod>2009-04-27T01:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/934a0keryx_biopharmaceuticals_names_interim_chairman_an-2/</loc>
		<lastmod>2009-04-27T02:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f6484cigna_and_merck_sign_agreement_for_oral_antidiabetes_medica-2/</loc>
		<lastmod>2009-04-27T02:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/174afnicox_to_acquire_nodonating_patents_from_nit-2/</loc>
		<lastmod>2009-04-27T03:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/124b1accumetrics_signs_distribution_agreement_with_el-2/</loc>
		<lastmod>2009-04-27T03:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_authorizes_emergency_use_of_influenza_medicines_diagnostic_test_in_response_to_swine_flu_outbreak_in_humans_090427-2/</loc>
		<lastmod>2009-04-27T04:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/topica_initiates_enrollment_in_phase_ii_study_of_antifungal_drug_270409-2/</loc>
		<lastmod>2009-04-27T04:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aua_counters_mainstream_recommendations_with_new_best_practice_statement_on_prostatespecific_antigen_testing_090427-2/</loc>
		<lastmod>2009-04-27T05:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/esperance_reports_positive_preclinical_results_from_cancer_study_270409-2/</loc>
		<lastmod>2009-04-27T05:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioms_medical_obtains_positive_review_for_phase_iii_multiple_sclerosis_trial_270409-2/</loc>
		<lastmod>2009-04-27T05:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abiomed_wins_fda_clearance_for_new_circulatory_support_devices_270409-2/</loc>
		<lastmod>2009-04-27T05:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lilly_obtains_preliminary_injunction_to_prevent_launch_of_tevas_generic_evista_270409-2/</loc>
		<lastmod>2009-04-27T06:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ethicon_wins_fda_approval_for_ide_application_to_start_study_of_notes_toolbox_270409-2/</loc>
		<lastmod>2009-04-27T06:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/874abantisense_pharma_initiates_phase_iii_brain_tumor_-2/</loc>
		<lastmod>2009-04-27T07:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tranzyme_pharma_reports_positive_results_from_phase_ii_gastroparesis_trial_270409-2/</loc>
		<lastmod>2009-04-27T07:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/294bdcellectricon_forms_collaboration_with_biofocu-2/</loc>
		<lastmod>2009-04-27T07:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bd48dapatech_reports_promising_data_from_synthetic_bone_graft_-2/</loc>
		<lastmod>2009-04-27T07:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanaria_initiates_phase_i_malaria_vaccine_trial_270409-2/</loc>
		<lastmod>2009-04-27T07:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/604a7quickmed_and_avery_dennison_sign_development_agre-2/</loc>
		<lastmod>2009-04-27T07:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4e483alr_technologies_signs_contract_with_pgb_me-2/</loc>
		<lastmod>2009-04-27T07:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c84b6celera_signs_licensing_agreement_with_per-2/</loc>
		<lastmod>2009-04-27T07:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medicinova_reports_encouraging_results_from_phase_ii_asthma_trial_270409-2/</loc>
		<lastmod>2009-04-27T07:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/94494covidien_introduces_duet_trs_reload_with_tissue_reinforc-2/</loc>
		<lastmod>2009-04-27T07:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8c4b8pfizer_and_ucl_sign_collaboration_and_licensing_agre-2/</loc>
		<lastmod>2009-04-27T07:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3d4aaneovasc_raises_c2_million_in_private_plac-2/</loc>
		<lastmod>2009-04-27T07:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/57484roche_and_slcg_partner_for_phase_iii_lung_cancer_-2/</loc>
		<lastmod>2009-04-27T07:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1149abovie_medical_names_new_board_m-2/</loc>
		<lastmod>2009-04-27T07:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/194bearena_pharmaceuticals_to_reduce_workforce_b-2/</loc>
		<lastmod>2009-04-27T07:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b44b5bayer_and_onyx_suspend_phase_iii_melanoma_-2/</loc>
		<lastmod>2009-04-27T07:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a7488sequenom_implements_cost_cutting_initiatives_axes_30-2/</loc>
		<lastmod>2009-04-27T07:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genesis_pharmaceuticals_launches_three_new_tcm_products_270409-2/</loc>
		<lastmod>2009-04-27T08:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/poniard_reports_encouraging_results_from_phase_i_colorectal_cancer_trial_270409-2/</loc>
		<lastmod>2009-04-27T08:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f54b3humana_names_new_board_m-2/</loc>
		<lastmod>2009-04-27T09:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d148dscynexis_reports_positive_results_from_phase_ib_hepatitis_-2/</loc>
		<lastmod>2009-04-27T09:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a249abristolmyers_reports_positive_interim_results_from_phase_ib_hepatitis_-2/</loc>
		<lastmod>2009-04-27T09:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immunomedics_reports_encouraging_preclinical_results_from_cancer_study_270409-3/</loc>
		<lastmod>2009-04-27T09:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a2497intarcia_therapeutics_completes_enrollment_in_phase_ib_diabetes_-3/</loc>
		<lastmod>2009-04-27T09:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5149croche_and_pharmasset_initiate_dosing_in_phase_iib_hepatitis_-3/</loc>
		<lastmod>2009-04-27T09:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b248abiolex_reports_encouraging_results_from_phase_iia_hepatitis_-2/</loc>
		<lastmod>2009-04-27T09:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aveo_reports_positive_preclinical_data_from_liver_cancer_trial_270409-2/</loc>
		<lastmod>2009-04-27T09:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3949fglobeimmune_reports_encouraging_interim_data_from_phase_ii_hepatitis_-2/</loc>
		<lastmod>2009-04-27T09:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c0484roche_launches_new_copay_program_in_pennsyl-2/</loc>
		<lastmod>2009-04-27T09:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/674b4covalon_and_amsino_form_all-2/</loc>
		<lastmod>2009-04-27T09:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1248dvasogen_names_new_cha-2/</loc>
		<lastmod>2009-04-27T09:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/77491celsion_initiates_enrollment_in_phase_iii_breast_cancer_-2/</loc>
		<lastmod>2009-04-27T10:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f4482infusystem_names_new_chief_commercial_of-2/</loc>
		<lastmod>2009-04-27T10:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/734b6thermo_fisher_scientific_to_acquire_biolab_for_a175_mi-2/</loc>
		<lastmod>2009-04-27T10:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6848fst_jude_medical_wins_ce_mark_for_merlinnet_patient_care_ne-2/</loc>
		<lastmod>2009-04-27T10:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5b4absru_biosystems_expands_its_line_of_labelfree_bind_biose-2/</loc>
		<lastmod>2009-04-27T10:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/exact_sciences_names_james_connelly_and_katherine_napier_to_its_board_090427-2/</loc>
		<lastmod>2009-04-27T10:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4e486perkinelmer_signs_contract_with_id_biological_sy-2/</loc>
		<lastmod>2009-04-27T10:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/844b9nitromed_announces_closing_of_its_acquisition_by_deerfield_manag-2/</loc>
		<lastmod>2009-04-27T11:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ad4bfroche_intermune_and_pharmasset_report_positive_results_from_hepatitis_-2/</loc>
		<lastmod>2009-04-27T11:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/464b8glaxosmithklines_phase_ii_diabetic_neuropathy_trial_fails_primary_end-2/</loc>
		<lastmod>2009-04-27T11:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a64abchina_medical_wins_sfda_approval_for_bladder_cancer_fish_-2/</loc>
		<lastmod>2009-04-27T11:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5c48dvitrolife_establishes_new_company_in_-2/</loc>
		<lastmod>2009-04-27T11:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d34b1sepracor_reports_encouraging_results_from_phase_iii_allergic_rhinitis_-2/</loc>
		<lastmod>2009-04-27T11:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/094aahuman_genome_sciencess_phase_iii_hepatitis_trials_meet_end-2/</loc>
		<lastmod>2009-04-27T11:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inverness_medical_reports_net_income_of_63_million_in_q1_2009_090427-2/</loc>
		<lastmod>2009-04-27T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche_diagnostics_india_plans_to_launch_tissuediagnostic_products_090428-2/</loc>
		<lastmod>2009-04-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/214bfgeron_makes_senior_management_ch-2/</loc>
		<lastmod>2009-04-28T01:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d5482ats_medical_names_new_vice_president_of_mark-2/</loc>
		<lastmod>2009-04-28T08:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aa493hearusa_divests_canadian_subsidiary_for_237_mi-2/</loc>
		<lastmod>2009-04-28T08:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ae4aephase_forward_signs_licensing_and_services_agreement_with_novo_no-2/</loc>
		<lastmod>2009-04-28T09:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ca48falkermess_partner_janssen_wins_japanese_approval_for_schizophrenia-2/</loc>
		<lastmod>2009-04-28T09:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dd48atrevena_names_new_board_m-2/</loc>
		<lastmod>2009-04-28T09:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/82494dr_reddys_launches_acne_drug_in_-2/</loc>
		<lastmod>2009-04-28T09:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9e4b3icon_acquires_phase_i_facility_from_qualia_clinical_ser-2/</loc>
		<lastmod>2009-04-28T09:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/334bbalgonomics_wins_12_million_research_funding_from_flemish_gover-2/</loc>
		<lastmod>2009-04-28T09:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8948ceurand_names_new_chief_research_of-2/</loc>
		<lastmod>2009-04-28T09:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f1496china_biologic_wins_53_million_contract_from_indian_distri-2/</loc>
		<lastmod>2009-04-28T09:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/54497pacific_biometrics_names_new_vice_president_of_science_and_techn-2/</loc>
		<lastmod>2009-04-28T09:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ea487encorium_signs_2_million_new_business_cont-2/</loc>
		<lastmod>2009-04-28T10:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0b4bfhospira_names_new_corporate_vice_president_of_supply_-2/</loc>
		<lastmod>2009-04-28T10:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9049dvisiogen_raises_40_million_in_equity_fina-2/</loc>
		<lastmod>2009-04-28T10:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c04a8exact_sciences_names_two_new_board_me-2/</loc>
		<lastmod>2009-04-28T10:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/444b3orexigen_names_new_svp_of_regulatory_affairs_and_product_develo-2/</loc>
		<lastmod>2009-04-28T10:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/764a2nextbio_signs_licensing_agreement_with_-2/</loc>
		<lastmod>2009-04-28T10:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c84aeamerican_caresource_signs_new_client_service_agreement_with_healthma-2/</loc>
		<lastmod>2009-04-28T10:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6549adiagnostic_imaging_international_and_cts_sign_new_con-2/</loc>
		<lastmod>2009-04-28T10:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b249apatheon_signs_agreements_to_commercialize_two_oros_technologybased_pro-2/</loc>
		<lastmod>2009-04-28T10:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristolmyers_posts_net_earnings_of_638_million_in_q1_2009_090428-2/</loc>
		<lastmod>2009-04-28T12:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ridge_diagnostics_wins_phase_ii_national_science_foundation_grant_280409-2/</loc>
		<lastmod>2009-04-28T13:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/centocor_wins_fda_approval_for_once_monthly_arthritis_therapy_280409-2/</loc>
		<lastmod>2009-04-28T13:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/actelion_wins_positive_opinion_for_pediatric_formulation_of_hypertension_drug_280409-2/</loc>
		<lastmod>2009-04-28T13:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/beckman_coulter_posts_net_earnings_of_206_million_in_q1_2009_090428-2/</loc>
		<lastmod>2009-04-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kyowa_posts_net_income_of_jpy117_billion_for_q1_fiscal_2009_090428-2/</loc>
		<lastmod>2009-04-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perkinelmer_appoints_frank_a_wilson_as_svp_cao_and_cfo_090429-2/</loc>
		<lastmod>2009-04-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perkinelmer_names_robert_f_friel_as_chairman_of_the_board_of_directors_090429-2/</loc>
		<lastmod>2009-04-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/surmodics_posts_42_million_net_income_in_q2_fiscal_2009_090429-2/</loc>
		<lastmod>2009-04-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/photocure_posts_net_loss_of_nok86_million_in_q1_2009_090429-2/</loc>
		<lastmod>2009-04-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3a4aeencorium_group_q4_net_loss_w-2/</loc>
		<lastmod>2009-04-29T03:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2248apfizer_q1_net_income-2/</loc>
		<lastmod>2009-04-29T03:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/advamed_medical_technology_and_the_swine_flu_epidemic_090429-2/</loc>
		<lastmod>2009-04-29T05:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7d495sinobiopharma_acquires_rights_to_seven_key_pa-2/</loc>
		<lastmod>2009-04-29T07:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a3487etex_wins_fda_clearance_for_small_size_bone_substitute_mate-2/</loc>
		<lastmod>2009-04-29T07:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/884aaprotaffin_secures_184_million_in_equity_fina-2/</loc>
		<lastmod>2009-04-29T07:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/984b1inimex_begins_clinical_trial_of_innate_defense_regu-2/</loc>
		<lastmod>2009-04-29T07:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c948cinsulet_obtains_ce_mark_for_omnipod_insulin_management_s-2/</loc>
		<lastmod>2009-04-29T07:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aa498pmi_files_marketing_application_for_idrive_ipu_and_iconsole_mo-2/</loc>
		<lastmod>2009-04-29T07:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7a4a2bmp_sunstone_names_new_board_m-2/</loc>
		<lastmod>2009-04-29T09:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/03482rxi_pharmaceuticals_names_new_board_m-2/</loc>
		<lastmod>2009-04-29T09:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/074b7ardea_biosciences_and_bayer_healthcare_partner_in_cancer_drug_develo-2/</loc>
		<lastmod>2009-04-29T09:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d04b8aps_and_biomodels_form_alliance_to_boost_supportive_cancer-2/</loc>
		<lastmod>2009-04-29T09:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b64bcavi_biopharma_wins_new_patents_for_ebola_zaire_infection_th-2/</loc>
		<lastmod>2009-04-29T09:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4149cgenta_to_obtain_two_new_european_patents_for_cancer-2/</loc>
		<lastmod>2009-04-29T09:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b54bfapplied_biosystems_and_geospiza_launch_new_genetic_analysis_sol-2/</loc>
		<lastmod>2009-04-29T09:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/444b5sinovac_wins_rmb87_million_purchase_order_from_chinese_gover-2/</loc>
		<lastmod>2009-04-29T09:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e3488aperio_wins_new_us_patent_for_contentbased_image_retrieval_techn-2/</loc>
		<lastmod>2009-04-29T09:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/524b2kendles_senior_vice_president_and_cfo_to_-2/</loc>
		<lastmod>2009-04-29T10:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/004a5alnylam_and_isis_partner_to_develop_singlestranded_rnai_techn-2/</loc>
		<lastmod>2009-04-29T10:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/45487ceragenix_and_mast_biosurgery_sign_joint_development_agre-2/</loc>
		<lastmod>2009-04-29T10:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2249aauxiliums_bla_for_dupuytrens_contracture_drug_wins_fda_priority_r-2/</loc>
		<lastmod>2009-04-29T10:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b04a1anaspec_establishes_new_headquarters_in_fremont_calif-2/</loc>
		<lastmod>2009-04-29T10:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2248dmako_surgical_names_new_svp_of_strategic_marketing_and_business_develo-2/</loc>
		<lastmod>2009-04-29T10:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/spongetech_delivery_systems_launches_new_medical_division_290409-2/</loc>
		<lastmod>2009-04-29T10:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b0481isto_technologies_wins_fda_approval_to_initiate_phase_i_back_pain_-2/</loc>
		<lastmod>2009-04-29T10:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a64b3medlink_signs_affiliation_agreement_with_clinical_laboratory_managem-2/</loc>
		<lastmod>2009-04-29T10:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7649aparticle_sciences_names_new_director_of_quality_assu-2/</loc>
		<lastmod>2009-04-29T10:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2e482wafergen_and_duke_university_medical_center_form_research_collabor-2/</loc>
		<lastmod>2009-04-29T10:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6f488imaging_diagnostic_systems_selects_neomedica_as_distributor_for_eastern_eur-2/</loc>
		<lastmod>2009-04-29T10:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ce48ccompendia_bioscience_and_mds_pharma_form_cancer_drug_collabor-2/</loc>
		<lastmod>2009-04-29T10:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pronova_biopharma_files_lawsuit_against_teva_pharmaceuticals_290409-2/</loc>
		<lastmod>2009-04-29T11:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medtronic_initiates_post_market_study_of_talent_thoracic_stent_graft_290409-2/</loc>
		<lastmod>2009-04-29T11:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ioptima_reports_encouraging_results_from_glaucoma_treatment_study_290409-2/</loc>
		<lastmod>2009-04-29T11:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perkinelmer_and_cerep_expand_new_kinase_assay_offerings_290409-2/</loc>
		<lastmod>2009-04-29T12:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/visiogen_raises_40_million_in_equity_financing_290409-2/</loc>
		<lastmod>2009-04-29T12:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/peregrine_reports_positive_data_from_second_phase_ii_breast_cancer_trial_290409-2/</loc>
		<lastmod>2009-04-29T12:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmings_prodarsan_obtains_orphan_drug_status_290409-2/</loc>
		<lastmod>2009-04-29T12:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ferring_pharmaceuticals_initiates_phase_iiib_prostate_cancer_trial_290409-2/</loc>
		<lastmod>2009-04-29T13:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sangamo_posts_net_loss_of_68_million_in_q1_2009_090429-2/</loc>
		<lastmod>2009-04-29T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abaxis_reports_12_million_net_income_for_fiscal_2009_090429-2/</loc>
		<lastmod>2009-04-29T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/iris_international_posts_14_million_profit_for_q1_2009_090429-2/</loc>
		<lastmod>2009-04-29T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/covance_posts_profit_of_403_million_for_q1_2009_090429-2/</loc>
		<lastmod>2009-04-29T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medigene_appoints_dr_frank_mathias_as_new_ceo_090429-2/</loc>
		<lastmod>2009-04-29T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sequenom_posts_175_million_net_loss_for_q1_2009_090429-2/</loc>
		<lastmod>2009-04-29T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/myriad_genetics_launches_new_molecular_diagnostic_product_290409-2/</loc>
		<lastmod>2009-04-29T14:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer_announces_q1_results_290409-2/</loc>
		<lastmod>2009-04-29T17:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/umicore_and_solvias_form_collaboration_290409-2/</loc>
		<lastmod>2009-04-29T17:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perkinelmer_posts_106_million_net_income_for_q1_2009_090430-2/</loc>
		<lastmod>2009-04-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/covidien_posts_184_million_profit_in_q2_fiscal_2009_090430-2/</loc>
		<lastmod>2009-04-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abraxis_bioscience_appoints_leon_moulder_as_vice_chairman_president_and_ceo_090430-2/</loc>
		<lastmod>2009-04-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f44baverathon_launches_new_bladder_volume_d-2/</loc>
		<lastmod>2009-04-30T03:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0d4b9response_biomedical_files_for_fda_clearance_of_rsv-2/</loc>
		<lastmod>2009-04-30T03:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c4486sigmaaldrich_launches_new_rnai_screening-2/</loc>
		<lastmod>2009-04-30T04:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/844a0imquest_and_arisyn_partner_to_develop_infectious_disease_and_cancer_dr-2/</loc>
		<lastmod>2009-04-30T04:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/87480united_therapeutics_names_new_board_m-2/</loc>
		<lastmod>2009-04-30T05:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fe498medical_nutrition_usa_launches_new_prostat_awc_with_citru-2/</loc>
		<lastmod>2009-04-30T05:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/59485amri_and_chdi_form_drug_discovery_collabor-2/</loc>
		<lastmod>2009-04-30T05:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/224adsimulations_plus_introduces_dddplus_versio-2/</loc>
		<lastmod>2009-04-30T05:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/064a7starch_medical_introduces_perclot_laparoscopic_hem-2/</loc>
		<lastmod>2009-04-30T05:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bial_and_eisai_announce_eu_marketing_approval_for_anti_epileptic_drug_300409-2/</loc>
		<lastmod>2009-04-30T05:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3a494amylin_and_lilly_partner_to_develop_new_pen_device_for_diabetes_th-2/</loc>
		<lastmod>2009-04-30T05:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4749csequenom_delays_launch_of_sequredx_down_syndrome-2/</loc>
		<lastmod>2009-04-30T05:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_q1_net_income_down_to_273_billion_300409-2/</loc>
		<lastmod>2009-04-30T05:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sciele_pharma_and_plethora_present_encouraging_results_from_phase_iii_pe_trial_300409-2/</loc>
		<lastmod>2009-04-30T06:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shoppers_drug_mart_q1_net_earnings_up_by_61_300409-2/</loc>
		<lastmod>2009-04-30T07:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ucb_presents_top_line_results_from_two_phase_iii_studies_of_seizure_drug_300409-2/</loc>
		<lastmod>2009-04-30T07:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/82480oxford_biomedica_and_sanofiaventis_collaborate_for_ocular_disease_trea-2/</loc>
		<lastmod>2009-04-30T07:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmalink_completes_phase_ii_study_of_renal_disease_drug_300409-2/</loc>
		<lastmod>2009-04-30T07:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/804b6sanofiaventis_q1_net_income_up_b-2/</loc>
		<lastmod>2009-04-30T07:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vaxinnate_reports_positive_results_from_phase_i_flu_vaccine_study_300409-2/</loc>
		<lastmod>2009-04-30T07:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f8482bristolmyers_squibb_q1_net_income-2/</loc>
		<lastmod>2009-04-30T07:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f24b0dynavax_reports_net_income_f-2/</loc>
		<lastmod>2009-04-30T07:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/094a2phase_forward_q1_net_income_increases_sli-2/</loc>
		<lastmod>2009-04-30T07:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dendreon_reports_encouraging_preclinical_data_from_bph_study_300409-2/</loc>
		<lastmod>2009-04-30T07:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3a4adbeckman_coulter_q1_net_income_falls_by_nearl-2/</loc>
		<lastmod>2009-04-30T07:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d94a8hospira_reports_153_surge_in_q1_net_i-2/</loc>
		<lastmod>2009-04-30T07:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/protaffin_secures_184m_in_equity_financing_300409-2/</loc>
		<lastmod>2009-04-30T07:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e24b4bayer_and_regeneron_extend_development_program_for_ophthalmic-2/</loc>
		<lastmod>2009-04-30T08:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/crucell_and_aeras_initiate_phase_i_tuberculosis_vaccine_trial_in_infants_300409-2/</loc>
		<lastmod>2009-04-30T08:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e74a4smith__nephew_names_new_president_for_advanced_wound_management_bus-2/</loc>
		<lastmod>2009-04-30T08:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a5490perkinelmer_names_ne-2/</loc>
		<lastmod>2009-04-30T08:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1c48ehra_pharma_names_ne-2/</loc>
		<lastmod>2009-04-30T08:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ed491revlon_names_new_president_an-2/</loc>
		<lastmod>2009-04-30T08:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1248fgenprobe_and_diagnocure_amend_licensing_agre-2/</loc>
		<lastmod>2009-04-30T08:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/594aasangamo_biosciences_q1_net_loss_na-2/</loc>
		<lastmod>2009-04-30T08:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a4484antigenics_wins_orphan_drug_designation_for_brain_cancer_va-2/</loc>
		<lastmod>2009-04-30T08:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6a4becovance_q1_net_income_dec-2/</loc>
		<lastmod>2009-04-30T08:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/434aek2m_launches_new_injectable_polymer_techn-2/</loc>
		<lastmod>2009-04-30T08:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5f485marinomed_wins_new_european_p-2/</loc>
		<lastmod>2009-04-30T08:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a94b0genenews_to_develop_new_bloodbased_diagnostic_-2/</loc>
		<lastmod>2009-04-30T08:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bb4b6sernova_names_new_president_an-2/</loc>
		<lastmod>2009-04-30T08:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/634a5seegene_launches_new_diarrhea-2/</loc>
		<lastmod>2009-04-30T08:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e6485perkinelmer_names_new_board_cha-2/</loc>
		<lastmod>2009-04-30T08:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/264baec_medical_intelligence_changes_name_to_pe-2/</loc>
		<lastmod>2009-04-30T09:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/20481impulse_monitoring_signs_agreement_with_nash_health-2/</loc>
		<lastmod>2009-04-30T09:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f749aameritox_signs_contract_with_aetna_for_prescription_drug_monitoring_ser-2/</loc>
		<lastmod>2009-04-30T09:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pacgen_to_acquire_xphase_pharmaceuticals_300409-2/</loc>
		<lastmod>2009-04-30T09:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1e49cimaging_diagnostic_systems_appoints_socrate_medical_as_distributor_for_-2/</loc>
		<lastmod>2009-04-30T09:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/474bebiomatrix_and_entest_biomedical_sign_contract_with_ucla_resea-2/</loc>
		<lastmod>2009-04-30T09:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6348eev3_initiates_enrollment_in_peripheral_arterial_disease_treatment_-2/</loc>
		<lastmod>2009-04-30T09:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c2489medicago_begins_work_on_swine_flu_s-2/</loc>
		<lastmod>2009-04-30T09:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eb48airidex_launches_new_iq_577_laser_sy-2/</loc>
		<lastmod>2009-04-30T09:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/df4a3addex_reports_encouraging_results_from_phase_iia_migraine_-2/</loc>
		<lastmod>2009-04-30T09:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/094a1wyeth_q1_net_income_increases_sli-2/</loc>
		<lastmod>2009-04-30T10:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/isotechnikas_phase_iii_psoriasis_trial_meets_primary_endpoint_300409-2/</loc>
		<lastmod>2009-04-30T10:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ocera_reports_positive_data_from_phase_ii_hepatic_encephalopathy_trial_300409-2/</loc>
		<lastmod>2009-04-30T11:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nanoviricides_to_develop_new_anti_flu_drug_against_all_influenza_types_300409-2/</loc>
		<lastmod>2009-04-30T11:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novo_posts_profit_of_dkk26_billion_for_q1_2009_090430-2/</loc>
		<lastmod>2009-04-30T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genprobe_reports_net_income_of_257_million_for_q1_2009_090430-2/</loc>
		<lastmod>2009-04-30T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amag_posts_net_loss_of_264_million_in_q1_2009_090430-2/</loc>
		<lastmod>2009-04-30T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/johnson_bottini_files_class_action_lawsuit_against_sequenom_090501-2/</loc>
		<lastmod>2009-05-01T05:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wyeth_q1_net_income_increases_slightly_to_1198_billion_010509-2/</loc>
		<lastmod>2009-05-01T09:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/phase_forward_q1_net_income_increases_slightly_to_408m_010509-2/</loc>
		<lastmod>2009-05-01T13:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lipoxen_and_cambridge_biostability_present_positive_data_for_flu_vaccine_010509-2/</loc>
		<lastmod>2009-05-01T14:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/milestone_scientific_grants_marketing_rights_for_sta_system_to_sinopharm_010509-2/</loc>
		<lastmod>2009-05-01T14:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/basilea_wins_dutch_approval_for_eczema_drug_010509-2/</loc>
		<lastmod>2009-05-01T14:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oxford_biomedica_regains_worldwide_rights_to_trovax_cancer_vaccine_010509-2/</loc>
		<lastmod>2009-05-01T15:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immunocellular_therapeutics_wins_new_patent_for_monoclonal_antibody_technology_010509-2/</loc>
		<lastmod>2009-05-01T15:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medicis_and_ipsen_win_fda_approval_for_dysport_010509-2/</loc>
		<lastmod>2009-05-01T15:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zymogenetics_reduces_workforce_by_32_010509-2/</loc>
		<lastmod>2009-05-01T16:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bd_and_fujirebio_sign_worldwide_agreement_to_develop_biomarker_assays_to_improve_cancer_detection_and_management_090504-2/</loc>
		<lastmod>2009-05-03T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/104aasolta_medical_wins_chinese_approval_to_market_thermage_sy-2/</loc>
		<lastmod>2009-05-04T05:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/214bbcelera_names_new_vice_president_and_chief_of_medical_af-2/</loc>
		<lastmod>2009-05-04T05:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f3497imris_wins_ce_mark_approval_for_interventional_imaging_s-2/</loc>
		<lastmod>2009-05-04T05:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nih_awards_new_grants_to_fund_international_research_collaborations_090504-2/</loc>
		<lastmod>2009-05-04T05:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3049dabraxis_bioscience_names_new_president_an-2/</loc>
		<lastmod>2009-05-04T05:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3f48dapplied_genetic_technologies_secures_118_million_in_fina-2/</loc>
		<lastmod>2009-05-04T05:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c9490optherion_wins_two_new_canadian_pa-2/</loc>
		<lastmod>2009-05-04T05:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ef484alseres_and_bioaxone_amend_licensing_agre-2/</loc>
		<lastmod>2009-05-04T05:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4b4b7supergens_chief_medical_officer_l-2/</loc>
		<lastmod>2009-05-04T08:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/75494medipattern_signs_contract_with_zwangerpesiri_radi-2/</loc>
		<lastmod>2009-05-04T09:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3b480inclinix_and_datatrak_form_partne-2/</loc>
		<lastmod>2009-05-04T09:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d8498phase_forward_signs_contract_with_everest_clinical_research_ser-2/</loc>
		<lastmod>2009-05-04T09:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/instrumentation_laboratory_wins_patent_infringement_and_unfair_competition_trial_against_diagnostica_stago_relating_to_reagents_for_hemostasis_diagnostics_090504-2/</loc>
		<lastmod>2009-05-04T09:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8c49cnfocus_neuromedical_names_new_board_cha-2/</loc>
		<lastmod>2009-05-04T09:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/454a7amdl_signs_agreement_with_precision_diagnostic_laboratory_for_cancer_t-2/</loc>
		<lastmod>2009-05-04T09:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/954badara_biosciences_names_new_board_m-2/</loc>
		<lastmod>2009-05-04T09:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/81497globus_medical_names_new_svp_of_international_and_corporate_progr-2/</loc>
		<lastmod>2009-05-04T09:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7d4a8duramed_introduces_new_oral_contrace-2/</loc>
		<lastmod>2009-05-04T09:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a3485china_pharma_holdings_names_new_cfo_and_board_m-2/</loc>
		<lastmod>2009-05-04T09:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/07482imaging_diagnostic_systems_names_new_managing_director_for_-2/</loc>
		<lastmod>2009-05-04T09:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ad4aeresonant_medical_names_new_vice_president_of_global_sales_and_mark-2/</loc>
		<lastmod>2009-05-04T10:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3d4bfphotothera_raises_50_million_in_financing_names_new_president_an-2/</loc>
		<lastmod>2009-05-04T10:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f5494catalyst_rx_and_state_of_mississippi_extend_pbm_con-2/</loc>
		<lastmod>2009-05-04T10:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9b4a5saladax_biomedicals_partner_myriad_genetics_launches_new_cancer-2/</loc>
		<lastmod>2009-05-04T10:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b1499rosetta_genomics_closes_licensing_and_collaboration_agre-2/</loc>
		<lastmod>2009-05-04T10:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6b4b1ipsogen_signs_licensing_agreement_with_arup_laborator-2/</loc>
		<lastmod>2009-05-04T10:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/664baconnectyx_signs_licensing_agreement_with_instant_medical_hi-2/</loc>
		<lastmod>2009-05-04T10:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/swine_flu_is_sweet_pill_for_roche_and_gsk_040509-2/</loc>
		<lastmod>2009-05-04T11:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/swine_flu_pandemic_alert_040509-2/</loc>
		<lastmod>2009-05-04T12:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cougar_biotechnology_initiates_phase_iii_prostate_cancer_trial_040509-2/</loc>
		<lastmod>2009-05-04T12:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gen_probe_to_initiate_clinical_study_of_prostate_cancer_test_040509-2/</loc>
		<lastmod>2009-05-04T12:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/procure_and_iba_win_fda_clearance_for_new_patient_positioning_system_040509-2/</loc>
		<lastmod>2009-05-04T13:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sigmaaldrich_announces_directorate_changes_090505-2/</loc>
		<lastmod>2009-05-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ge_healthcare_signs_agreement_with_harrison_for_hit_solutions_090505-2/</loc>
		<lastmod>2009-05-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/iflow_reports_net_loss_of_36_million_for_q1_2009_090505-2/</loc>
		<lastmod>2009-05-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/landauer_posts_net_income_of_54_million_in_q2_fiscal_2009_090505-2/</loc>
		<lastmod>2009-05-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perot_systems_posts_net_income_of_28_million_in_q1_2009_090505-2/</loc>
		<lastmod>2009-05-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/84495cerrx_acquires_rights_to_new_formulation_of_cancer_th-2/</loc>
		<lastmod>2009-05-05T00:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8f4bfdiscovery_laboratories_obtains_notice_of_allowance_for_new_us_p-2/</loc>
		<lastmod>2009-05-05T01:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/46492iflow_obtains_usptos_notice_of_intent_for_infusion_apparatus_p-2/</loc>
		<lastmod>2009-05-05T01:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9d49bbiotime_wins_47_million_grant_from-2/</loc>
		<lastmod>2009-05-05T01:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1b49callergan_q1_net_earnings_dec-2/</loc>
		<lastmod>2009-05-05T01:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/37482nfocus_neuromedical_names_new_vice_president_of_regulatory_af-2/</loc>
		<lastmod>2009-05-05T01:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sxc_health_solutions_implements_sterling_business_integration_suite_050509-2/</loc>
		<lastmod>2009-05-05T02:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/axentis_pharma_wins_orphan_designation_for_lung_infection_drug_050509-2/</loc>
		<lastmod>2009-05-05T05:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/warner_chilcott_files_new_patent_infringement_lawsuit_against_mylan_050509-2/</loc>
		<lastmod>2009-05-05T06:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/via_pharmaceuticals_reports_encouraging_results_from_phase_ii_acs_trial_050509-2/</loc>
		<lastmod>2009-05-05T07:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/photothera_raises_50m_in_financing_names_new_president_and_ceo_050509-2/</loc>
		<lastmod>2009-05-05T07:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ca486acclarent_awarded_key_patent_covering_balloon_sinuplasty_technol-2/</loc>
		<lastmod>2009-05-05T07:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tigris_initiates_dosing_in_phase_i_cancer_trial_050509-2/</loc>
		<lastmod>2009-05-05T08:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/can_fite_biopharmas_phase_iib_rheumatoid_arthritis_study_fails_endpoint_050509-2/</loc>
		<lastmod>2009-05-05T08:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fovea_reports_positive_results_from_allergic_conjunctivitis_trial_050509-2/</loc>
		<lastmod>2009-05-05T08:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c74a5health_discovery_names_new_president_and_general_co-2/</loc>
		<lastmod>2009-05-05T08:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/414b2pfizer_names_new_senior_vice_president_and_chief_medical_of-2/</loc>
		<lastmod>2009-05-05T08:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e148bbrainscope_names_new_board_m-2/</loc>
		<lastmod>2009-05-05T08:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fa4b8neurometrix_names_new_senior_vice_president_of_global_-2/</loc>
		<lastmod>2009-05-05T08:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3e4bbcmed_signs_partnership_agreement_with_tes-2/</loc>
		<lastmod>2009-05-05T09:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ee4a2peregrine_completes_enrollment_in_phase_ii_breast_cancer_-2/</loc>
		<lastmod>2009-05-05T09:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ef49acorespine_wins_fda_clearance_for_new_surgical_disc_preparation_d-2/</loc>
		<lastmod>2009-05-05T09:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2e493almirall_signs_licensing_agreement_with_ironwood_pharmaceutic-2/</loc>
		<lastmod>2009-05-05T09:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/094aabd_and_fujirebio_diagnostics_sign_development_and_supply_agre-2/</loc>
		<lastmod>2009-05-05T09:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a749bbiovail_signs_collaboration_and_licensing_agreement_with_a-2/</loc>
		<lastmod>2009-05-05T09:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/33485regenerx_wins_australian_patent_for_treating_eye_disorders_wi-2/</loc>
		<lastmod>2009-05-05T09:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmaxis_reports_positive_results_from_phase_iii_cystic_fibrosis_trial_050509-2/</loc>
		<lastmod>2009-05-05T09:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0a4b6circ_pharma_and_elan_sign_development_agre-2/</loc>
		<lastmod>2009-05-05T09:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/194a5xspine_wins_fda_clearance_for_calix_spinal_implant_s-2/</loc>
		<lastmod>2009-05-05T09:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7a4b3kamada_raises_7_million_in_fina-2/</loc>
		<lastmod>2009-05-05T09:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9249fzymogenetics_licenses_noncore_assets_to_seattle_life_sci-2/</loc>
		<lastmod>2009-05-05T10:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c14b0astrazeneca_files_nda_for_low_dose_aspirinesomeprazole_combination_pr-2/</loc>
		<lastmod>2009-05-05T10:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/33487djo_surgical_and_lima_corporate_form_partne-2/</loc>
		<lastmod>2009-05-05T10:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ab49eplc_systems_signs_distribution_agreement_with_iz-2/</loc>
		<lastmod>2009-05-05T10:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fe48ejubilant_forms_research_collaboration_with_astraz-2/</loc>
		<lastmod>2009-05-05T10:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/074afchina_aoxing_wins_new_injection_drug_approval_for_angina_trea-2/</loc>
		<lastmod>2009-05-05T10:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/excelsior_wins_fda_approval_for_new_luer_access_valve_disinfection_cap_050509-2/</loc>
		<lastmod>2009-05-05T12:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/exact_sciences_posts_revenues_of_1_million_for_q1_2009_090505-2/</loc>
		<lastmod>2009-05-05T15:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/durect_posts_net_loss_of_87_million_for_q1_2009_090506-2/</loc>
		<lastmod>2009-05-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thermogenesis_posts_net_loss_of_11_million_in_q3_fiscal_2008_090506-2/</loc>
		<lastmod>2009-05-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clarient_reports_revenues_of_224_million_for_q1_2009_090506-2/</loc>
		<lastmod>2009-05-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5349bophthotech_reports_positive_results_from_phase_i_wet_amd_-2/</loc>
		<lastmod>2009-05-05T23:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5a4b8neostem_acquires_rights_to_stem_cell_technology_for_healing_w-2/</loc>
		<lastmod>2009-05-05T23:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e74a5roxane_laboratories_launches_generic_transplant-2/</loc>
		<lastmod>2009-05-05T23:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1e4b2renato_to_enter_into_joint_venture_program_with_generic_drug_manufac-2/</loc>
		<lastmod>2009-05-06T00:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2f49cbayer_schering_to_start_phase_iii_studies_of_lowdose_contraceptive_-2/</loc>
		<lastmod>2009-05-06T00:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c84bemedtronic_introduces_vertex_select_reconstruction_s-2/</loc>
		<lastmod>2009-05-06T00:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a64b1clinical_data_and_university_of_pittsburgh_form_research_all-2/</loc>
		<lastmod>2009-05-06T00:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f74b6medtronic_introduces_peek_prevail_cervical_interbody_d-2/</loc>
		<lastmod>2009-05-06T00:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4549cwuxi_pharmatech_names_new_vice_president_of_fi-2/</loc>
		<lastmod>2009-05-06T00:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6b490teva_q1_net_income_s-2/</loc>
		<lastmod>2009-05-06T00:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/allergan_q1_net_earnings_decrease_to_45m_060509-2/</loc>
		<lastmod>2009-05-06T05:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ranbaxy_recalls_nitrofurantoin_capsules_060509-2/</loc>
		<lastmod>2009-05-06T05:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nih_grants_122_million_in_institutional_development_awards_090506-2/</loc>
		<lastmod>2009-05-06T05:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/714b1ergomed_and_genzyme_sign_codevelopment_agreement_for_cancer-2/</loc>
		<lastmod>2009-05-06T05:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/54481endosense_wins_ce_mark_for_tacticath_ablation_cat-2/</loc>
		<lastmod>2009-05-06T05:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7f485cephalon_q1_net_inco-2/</loc>
		<lastmod>2009-05-06T05:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astellas_pharma_reports_encouraging_results_from_overactive_bladder_study_060509-2/</loc>
		<lastmod>2009-05-06T06:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pulmatrix_to_initiate_phase_ibiia_trial_of_flu_drug_060509-2/</loc>
		<lastmod>2009-05-06T06:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ocimum_biosolutions_to_launch_new_test_for_h1n1_flu_060509-2/</loc>
		<lastmod>2009-05-06T07:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inspire_initiates_phase_ii_program_for_treatment_of_blepharitis_060509-2/</loc>
		<lastmod>2009-05-06T07:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_wins_fda_approval_for_blood_pressure_combination_therapy_060509-2/</loc>
		<lastmod>2009-05-06T07:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/solvay_pharmaceuticals_wins_fda_approval_for_pancreatic_disorder_drug_060509-2/</loc>
		<lastmod>2009-05-06T07:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0f49bzafgen_names_new_cfo_and_vice_president_of_business_develo-2/</loc>
		<lastmod>2009-05-06T08:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6b495calistoga_pharmaceuticals_secures_30_million_in_series_b_fina-2/</loc>
		<lastmod>2009-05-06T08:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d94b3perkinelmer_acquires_analytica_of_bra-2/</loc>
		<lastmod>2009-05-06T08:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/904a4candela_wins_canadian_approval_for_new_quadralase_fractional_-2/</loc>
		<lastmod>2009-05-06T09:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a1492strides_arcolab_begins_commercial_supplies_of_flu_drug-2/</loc>
		<lastmod>2009-05-06T09:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/644b5advandx_wins_fda_clearance_for_new_diagnostic-2/</loc>
		<lastmod>2009-05-06T09:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biotime_wins_47m_grant_from_cirm_060509-2/</loc>
		<lastmod>2009-05-06T09:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perceptive_informatics_launches_new_medical_imaging_methodology_060509-2/</loc>
		<lastmod>2009-05-06T09:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/534bctranzyme_pharma_initiates_dosing_in_phase_ii_gastroparesis_-2/</loc>
		<lastmod>2009-05-06T09:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neoprobe_reports_revenues_of_27_million_in_q1_2009_090506-2/</loc>
		<lastmod>2009-05-06T09:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f249astellar_pharmaceuticals_signs_licensing_agreement_with_s-2/</loc>
		<lastmod>2009-05-06T09:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/524a9oramed_pharmaceuticals_to_initiate_phase_iib_diabetes_-2/</loc>
		<lastmod>2009-05-06T09:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ba493hyperion_wins_orphan_drug_designation_for_urea_cycle_disorder-2/</loc>
		<lastmod>2009-05-06T09:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f9481nymox_initiates_second_phase_iii_benign_prostatic_hyperplasia_-2/</loc>
		<lastmod>2009-05-06T09:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/824a0integra_lifesciences_introduces_coral_extended_tab_spinal_screw_s-2/</loc>
		<lastmod>2009-05-06T10:24:00+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->